Document

eCFR :: 17 CFR 240.14a-101 -- Schedule 14A. Information required in proxy statement.

ICR 202609-3235-014 · OMB 3235-0059 · Object 173131000.

Document Viewer [pdf]

Status: Original and derived artifacts are available for this document.

Download: pdf

Primary: pdfSource: application/pdf
Loading document viewer…

Document Metadata

Record metadata
application/pdf
eCFR :: 17 CFR 240.14a-101 -- Schedule 14A. Information required in proxy statement.
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KH
2026-04-06
2026-04-06
complete

Extracted Text

This content is from the eCFR and is authoritative but unofficial.

 Displaying title 17, up to date as of 4/02/2026. Title 17 was last amended
3/31/2026.

Title 17 —Commodity and Securities Exchanges
Chapter II —Securities and Exchange Commission
Part 240 —General Rules and Regulations, Securities Exchange Act of 1934
Subpart A —Rules and Regulations Under the Securities Exchange Act of 1934
Regulation 14A: Solicitation of Proxies
EDITORIAL NOTE ON PART 240

Editorial Note: Nomenclature changes to part 240 appear at 57 FR 36501, Aug. 13, 1992, and 57 FR
47409, Oct. 16, 1992.

§ 240.14a-101 Schedule 14A. Information required in proxy statement.

Schedule 14A Information
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of
1934
(Amendment No. )
Filed by the Registrant [ ]
Filed by a party other than the Registrant [ ]
Check the appropriate box:
[ ] Preliminary Proxy Statement
[ ] Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
[ ] Definitive Proxy Statement
[ ] Definitive Additional Materials
[ ] Soliciting Material under § 240.14a-12
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check all boxes that apply):
[ ] No fee required
[ ] Fee paid previously with preliminary materials
[ ] Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 011

Notes
Notes: A. Where any item calls for information with respect to any matter to be acted upon and such
matter involves other matters with respect to which information is called for by other items of this
schedule, the information called for by such other items also shall be given. For example, where a

solicitation of security holders is for the purpose of approving the authorization of additional
securities which are to be used to acquire another specified company, and the registrants' security
holders will not have a separate opportunity to vote upon the transaction, the solicitation to
authorize the securities is also a solicitation with respect to the acquisition. Under those facts,
information required by Items 11, 13 and 14 shall be furnished.
B. Where any item calls for information with respect to any matter to be acted upon at the meeting,
such item need be answered in the registrant's soliciting material only with respect to proposals to
be made by or on behalf of the registrant.
C. Except as otherwise specifically provided, where any item calls for information for a specified
period with regard to directors, executive officers, officers or other persons holding specified
positions or relationships, the information shall be given with regard to any person who held any of
the specified positions or relationship at any time during the period. Information, other than
information required by Item 404 of Regulation S-K (§ 229.404 of this chapter), need not be included
for any portion of the period during which such person did not hold any such position or relationship,
provided a statement to that effect is made.
D. Information may be incorporated by reference only in the manner and to the extent specifically
permitted in the items of this schedule. Where incorporation by reference is used, the following shall
apply:
1. Disclosure must not be incorporated by reference from a second document if that second
document incorporates information pertinent to such disclosure by reference to a third document. A
registrant incorporating any documents, or portions of documents, shall include a statement on the
last page(s) of the proxy statement as to which documents, or portions of documents, are
incorporated by reference. Information shall not be incorporated by reference in any case where
such incorporation would render the statement incomplete, unclear or confusing.
2. If a document is incorporated by reference but not delivered to security holders, include an
undertaking to provide, without charge, to each person to whom a proxy statement is delivered,
upon written or oral request of such person and by first class mail or other equally prompt means
within one business day of receipt of such request, a copy of any and all of the information that has
been incorporated by reference in the proxy statement (not including exhibits to the information that
is incorporated by reference unless such exhibits are specifically incorporated by reference into the
information that the proxy statement incorporates), and the address (including title or department)
and telephone numbers to which such a request is to be directed. This includes information
contained in documents filed subsequent to the date on which definitive copies of the proxy
statement are sent or given to security holders, up to the date of responding to the request.
3. If a document or portion of a document other than an annual report sent to security holders
pursuant to the requirements of Rule 14a-3 (§ 240.14a-3 of this chapter) with respect to the same
meeting or solicitation of consents or authorizations as that to which the proxy statement relates is
incorporated by reference in the manner permitted by Item 13(b) or 14(e)(1) of this schedule, the
proxy statement must be sent to security holders no later than 20 business days prior to the date on
which the meeting of such security holders is held or, if no meeting is held, at least 20 business days
prior to the date the votes, consents or authorizations may be used to effect the corporate action.
4. Electronic filings. If any of the information required by Items 13 or 14 of this Schedule is
incorporated by reference from an annual or quarterly report to security holders, such report, or any
portion thereof incorporated by reference, shall be filed in electronic format with the proxy
statement. This provision shall not apply to registered investment companies.
5. Interactive Data File. An Interactive Data File must be included in accordance with § 232.405 of
this chapter and the EDGAR Filer Manual where applicable pursuant to § 232.405(b) of this chapter.

E. In Item 13 of this Schedule, the reference to “meets the requirement of Form S-3” or “meets the
requirements of General Instruction A.2 of Form N-2” shall refer to a registrant who meets the
following requirements:
(a) A registrant meets the requirements of Form S-3 if:
(1) The registrant meets the requirements of General Instruction I.A. of Form S-3 (§ 239.13 of this
chapter); and
(2) One of the following is met:
(i) The registrant meets the aggregate market value requirement of General Instruction I.B.1 of Form
S-3; or
(ii) Action is to be taken as described in Items 11, 12, and 14 of this schedule which concerns nonconvertible debt or preferred securities issued by a registrant meeting the requirements of General
Instruction I.B.2. of Form S-3 (referenced in 17 CFR 239.13); or
(iii) The registrant is a majority-owned subsidiary and one of the conditions of General Instruction
I.C. of Form S-3 is met.
(b) A registrant meets the requirements of General Instruction A.2 of Form N-2 (§§ 239.14 and
274.11a-1 of this chapter) if the registrant meets the conditions included in such General
Instruction, provided that General Instruction A.2.c of Form N-2 is subject to the same limitations
described in paragraph (a)(2) of this Note E.

Item 1. Date, time and place information. (a) State the date, time and place of the meeting of security
holders, and the complete mailing address, including ZIP Code, of the principal executive offices of
the registrant, unless such information is otherwise disclosed in material furnished to security
holders with or preceding the proxy statement. If action is to be taken by written consent, state the
date by which consents are to be submitted if state law requires that such a date be specified or if
the person soliciting intends to set a date.
(b) On the first page of the proxy statement, as delivered to security holders, state the approximate
date on which the proxy statement and form of proxy are first sent or given to security holders.
(c) Furnish the information required to be in the proxy statement by Rule 14a-5(e) (§ 240.14a-5(e) of
this chapter).

Item 2. Revocability of proxy. State whether or not the person giving the proxy has the power to
revoke it. If the right of revocation before the proxy is exercised is limited or is subject to compliance
with any formal procedure, briefly describe such limitation or procedure.

Item 3. Dissenters' right of appraisal. Outline briefly the rights of appraisal or similar rights of
dissenters with respect to any matter to be acted upon and indicate any statutory procedure
required to be followed by dissenting security holders in order to perfect such rights. Where such
rights may be exercised only within a limited time after the date of adoption of a proposal, the filing
of a charter amendment or other similar act, state whether the persons solicited will be notified of
such date.

Instructions. 1. Indicate whether a security holder's failure to vote against a proposal will constitute
a waiver of his appraisal or similar rights and whether a vote against a proposal will be deemed to
satisfy any notice requirements under State law with respect to appraisal rights. If the State law is
unclear, state what position will be taken in regard to these matters.
2. Open-end investment companies registered under the Investment Company Act of 1940 are not
required to respond to this item.

Item 4. Persons Making the Solicitation—(a) Solicitations not subject to Rule 14a-12(c) (§ 240.14a12(c)). (1) If the solicitation is made by the registrant, so state. Give the name of any director of the
registrant who has informed the registrant in writing that he intends to oppose any action intended
to be taken by the registrant and indicate the action which he intends to oppose.

(2) If the solicitation is made otherwise than by the registrant, so state and give the names of the
participants in the solicitation, as defined in paragraphs (a) (iii), (iv), (v) and (vi) of Instruction 3 to
this Item.
(3) If the solicitation is to be made otherwise than by the use of the mails or pursuant to § 240.14a16, describe the methods to be employed. If the solicitation is to be made by specially, engaged
employees or paid solicitors, state (i) the material features of any contract or arrangement for such
solicitation and identify the parties, and (ii) the cost or anticipated cost thereof.
(4) State the names of the persons by whom the cost of solicitation has been or will be borne,
directly or indirectly.
(b) Solicitations subject to Rule 14a-12(c) (§ 240.14a-12(c)). (1) State by whom the solicitation is
made and describe the methods employed and to be employed to solicit security holders.
(2) If regular employees of the registrant or any other participant in a solicitation have been or are to
be employed to solicit security holders, describe the class or classes of employees to be so
employed, and the manner and nature of their employment for such purpose.
(3) If specially engaged employees, representatives or other persons have been or are to be
employed to solicit security holders, state (i) the material features of any contract or arrangement
for such solicitation and the identity of the parties, (ii) the cost or anticipated cost thereof and (iii)
the approximate number of such employees of employees or any other person (naming such other
person) who will solicit security holders).
(4) State the total amount estimated to be spent and the total expenditures to date for, in
furtherance of, or in connection with the solicitation of security holders.
(5) State by whom the cost of the solicitation will be borne. If such cost is to be borne initially by any
person other than the registrant, state whether reimbursement will be sought from the registrant,
and, if so, whether the question of such reimbursement will be submitted to a vote of security
holders.
(6) If any such solicitation is terminated pursuant to a settlement between the registrant and any
other participant in such solicitation, describe the terms of such settlement, including the cost or
anticipated cost thereof to the registrant.

Instructions. 1. With respect to solicitations subject to Rule 14a-12(c) (§ 240.14a-12(c)), costs and
expenditures within the meaning of this Item 4 shall include fees for attorneys, accountants, public
relations or financial advisers, solicitors, advertising, printing, transportation, litigation and other
costs incidental to the solicitation, except that the registrant may exclude the amount of such costs
represented by the amount normally expended for a solicitation for an election of directors in the
absence of a contest, and costs represented by salaries and wages of regular employees and
officers, provided a statement to that effect is included in the proxy statement.
2. The information required pursuant to paragraph (b)(6) of this Item should be included in any
amended or revised proxy statement or other soliciting materials relating to the same meeting or
subject matter furnished to security holders by the registrant subsequent to the date of settlement.
3. For purposes of this Item 4 and Item 5 of this Schedule 14A:
(a) The terms “participant” and “participant in a solicitation” include the following:
(i) In the case of a solicitation made on behalf of the registrant, the registrant, each director of the
registrant and each of the registrant's nominees for election as a director;
(ii) In the case of a solicitation made otherwise than on behalf of the registrant, each of the
soliciting person's nominees for election as a director;
(iii) Any committee or group which solicits proxies, any member of such committee or group, and
any person whether or not named as a member who, acting alone or with one or more other
persons, directly or indirectly takes the initiative, or engages, in organizing, directing, or arranging for
the financing of any such committee or group;

(iv) Any person who finances or joins with another to finance the solicitation of proxies, except
persons who contribute not more than $500 and who are not otherwise participants;
(v) Any person who lends money or furnishes credit or enters into any other arrangements, pursuant
to any contract or understanding with a participant, for the purpose of financing or otherwise
inducing the purchase, sale, holding or voting of securities of the registrant by any participant or
other persons, in support of or in opposition to a participant; except that such terms do not include a
bank, broker or dealer who, in the ordinary course of business, lends money or executes orders for
the purchase or sale of securities and who is not otherwise a participant; and
(vi) Any person who solicits proxies.
(b) The terms “participant” and “participant in a solicitation” do not include:
(i) Any person or organization retained or employed by a participant to solicit security holders and
whose activities are limited to the duties required to be performed in the course of such
employment;
(ii) Any person who merely transmits proxy soliciting material or performs other ministerial or
clerical duties;
(iii) Any person employed by a participant in the capacity of attorney, accountant, or advertising,
public relations or financial adviser, and whose activities are limited to the duties required to be
performed in the course of such employment;
(iv) Any person regularly employed as an officer or employee of the registrant or any of its
subsidiaries who is not otherwise a participant; or
(v) Any officer or director of, or any person regularly employed by, any other participant, if such
officer, director or employee is not otherwise a participant.

Item 5. Interest of certain Persons in Matters To Be Acted Upon (a) Solicitations not subject to Rule
14a-12(c) (§ 240.14a-12(c)). Describe briefly any substantial interest, direct or indirect, by security
holdings or otherwise, of each of the following persons in any matter to be acted upon, other than
elections to office:
(1) If the solicitation is made on behalf of the registrant, each person who has been a director or
executive officer of the registrant at any time since the beginning of the last fiscal year.
(2) If the solicitation is made otherwise than on behalf of the registrant, each participant in the
solicitation, as defined in paragraphs (a) (iii), (iv), (v), and (vi) of Instruction 3 to Item 4 of this
Schedule 14A.
(3) Each nominee for election as a director of the registrant.
(4) Each associate of any of the foregoing persons.
(5) If the solicitation is made on behalf of the registrant, furnish the information required by Item
402(t) of Regulation S-K (§ 229.402(t) of this chapter).

Instruction to paragraph (a). Except in the case of a solicitation subject to this regulation
made in opposition to another solicitation subject to this regulation, this sub-item (a) shall
not apply to any interest arising from the ownership of securities of the registrant where
the security holder receives no extra or special benefit not shared on a pro rata basis by all
other holders of the same class.
(b) Solicitation subject to Rule 14a-12(c) (§ 240.14a-12(c)). With respect to any solicitation subject to
Rule 14a-12(c) (§ 240.14a-12(c)):
(1) Describe briefly any substantial interest, direct or indirect, by security holdings or otherwise, of
each participant as defined in paragraphs (a) (ii), (iii), (iv), (v) and (vi) of Instruction 3 to Item 4 of
this Schedule 14A, in any matter to be acted upon at the meeting, and include with respect to each
participant the following information, or a fair and accurate summary thereof:
(i) Name and business address of the participant.

(ii) The participant's present principal occupation or employment and the name, principal business
and address of any corporation or other organization in which such employment is carried on.
(iii) State whether or not, during the past ten years, the participant has been convicted in a criminal
proceeding (excluding traffic violations or similar misdemeanors) and, if so, give dates, nature of
conviction, name and location of court, and penalty imposed or other disposition of the case. A
negative answer need not be included in the proxy statement or other soliciting material.
(iv) State the amount of each class of securities of the registrant which the participant owns
beneficially, directly or indirectly.
(v) State the amount of each class of securities of the registrant which the participant owns of
record but not beneficially.
(vi) State with respect to all securities of the registrant purchased or sold within the past two years,
the dates on which they were purchased or sold and the amount purchased or sold on each such
date.
(vii) If any part of the purchase price or market value of any of the shares specified in paragraph (b)
(1)(vi) of this Item is represented by funds borrowed or otherwise obtained for the purpose of
acquiring or holding such securities, so state and indicate the amount of the indebtedness as of the
latest practicable date. If such funds were borrowed or obtained otherwise than pursuant to a
margin account or bank loan in the regular course of business of a bank, broker or dealer, briefly
describe the transaction, and state the names of the parties.
(viii) State whether or not the participant is, or was within the past year, a party to any contract,
arrangements or understandings with any person with respect to any securities of the registrant,
including, but not limited to joint ventures, loan or option arrangements, puts or calls, guarantees
against loss or guarantees of profit, division of losses or profits, or the giving or withholding of
proxies. If so, name the parties to such contracts, arrangements or understandings and give the
details thereof.
(ix) State the amount of securities of the registrant owned beneficially, directly or indirectly, by each
of the participant's associates and the name and address of each such associate.
(x) State the amount of each class of securities of any parent or subsidiary of the registrant which
the participant owns beneficially, directly or indirectly.
(xi) Furnish for the participant and associates of the participant the information required by Item
404(a) of Regulation S-K (§ 229.404(a) of this chapter).
(xii) State whether or not the participant or any associates of the participant have any arrangement
or understanding with any person—
(A) with respect to any future employment by the registrant or its affiliates; or
(B) with respect to any future transactions to which the registrant or any of its affiliates will or may
be a party.
If so, describe such arrangement or understanding and state the names of the parties thereto.
(2) With respect to any person, other than a director or executive officer of the registrant acting
solely in that capacity, who is a party to an arrangement or understanding pursuant to which a
nominee for election as director is proposed to be elected, describe any substantial interest, direct
or indirect, by security holdings or otherwise, that such person has in any matter to be acted upon at
the meeting, and furnish the information called for by paragraphs (b)(1) (xi) and (xii) of this Item.
(3) If the solicitation is made on behalf of the registrant, furnish the information required by Item
402(t) of Regulation S-K (§ 229.402(t) of this chapter).

Instruction to paragraph (b): For purposes of this Item 5, beneficial ownership shall be
determined in accordance with Rule 13d-3 under the Act (Section 240.13d-3 of this
chapter).

Item 6. Voting securities and principal holders thereof, (a) As to each class of voting securities of the
registrant entitled to be voted at the meeting (or by written consents or authorizations if no meeting
is held), state the number of shares outstanding and the number of votes to which each class is
entitled.
(b) State the record date, if any, with respect to this solicitation. If the right to vote or give consent is
not to be determined, in whole or in part, by reference to a record date, indicate the criteria for the
determination of security holders entitled to vote or give consent.
(c) If action is to be taken with respect to the election of directors and if the persons solicited have
cumulative voting rights: (1) Make a statement that they have such rights, (2) briefly describe such
rights, (3) state briefly the conditions precedent to the exercise thereof, and (4) if discretionary
authority to cumulate votes is solicited, so indicate.
(d) Furnish the information required by Item 403 of Regulation S-K (§ 229.403 of this chapter) to the
extent known by the persons on whose behalf the solicitation is made.
(e) If, to the knowledge of the persons on whose behalf the solicitation is made, a change in control
of the registrant has occurred since the beginning of its last fiscal year, state the name of the
person(s) who acquired such control, the amount and the source of the consideration used by such
person or persons; the basis of the control, the date and a description of the transaction(s) which
resulted in the change of control and the percentage of voting securities of the registrant now
beneficially owned directly or indirectly by the person(s) who acquired control; and the identity of the
person(s) from whom control was assumed. If the source of all or any part of the consideration
used is a loan made in the ordinary course of business by a bank as defined by section 3(a)(6) of
the Act, the identity of such bank shall be omitted provided a request for confidentiality has been
made pursuant to section 13(d)(1)(B) of the Act by the person(s) who acquired control. In lieu
thereof, the material shall indicate that the identity of the bank has been so omitted and filed
separately with the Commission.

Instruction. 1. State the terms of any loans or pledges obtained by the new control group for the
purpose of acquiring control, and the names of the lenders or pledgees.
2. Any arrangements or understandings among members of both the former and new control groups
and their associates with respect to election of directors or other matters should be described.

Item 7. Directors and executive officers. If action is to be taken with respect to the election of
directors, furnish the following information in tabular form to the extent practicable. If, however, the
solicitation is made on behalf of persons other than the registrant, the information required need be
furnished only as to nominees of the persons making the solicitation.
(a) The information required by Item 103(c)(2) of Regulation S-K (§ 229.103(c)(2) of this chapter)
with respect to directors and executive officers.
(b) The information required by Items 401, 404(a) and (b), 405, 407 and 408(b) of Regulation S-K (§§
229.401, 229.404(a) and (b), 229.405, 229.407, and 229.408(b) of this chapter), other than the
information required by:
(i) Paragraph (c)(3) of Item 407 of Regulation S-K (§ 229.407(c)(3) of this chapter); and
(ii) Paragraphs (e)(4) and (e)(5) of Item 407 of Regulation S-K (§§ 229.407(e)(4) and 229.407(e)(5)
of this chapter) (which are required by Item 8 of this Schedule 14A).
(c) [Reserved]
(d) If a registrant is required to include a shareholder nominee or nominees submitted to the
registrant for inclusion in the registrant's proxy materials pursuant to a procedure set forth under
applicable state or foreign law, or the registrant's governing documents providing for the inclusion of
shareholder director nominees in the registrant's proxy materials, the registrant must include in its
proxy statement the disclosure required from the nominating shareholder or nominating shareholder
group under Item 6 of § 240.14n-101 with regard to the nominee or nominees and the nominating
shareholder or nominating shareholder group.

(e) In lieu of the information required by this Item 7, investment companies registered under the
Investment Company Act of 1940 (15 U.S.C. 80a) must furnish the information required by Item
22(b) of this Schedule 14A.
(f) If a person is conducting a solicitation that is subject to § 240.14a-19, the registrant must include
in its proxy statement a statement directing shareholders to refer to any other soliciting person's
proxy statement for information required by Item 7 of this Schedule 14A with regard to such
person's nominee or nominees and a soliciting person other than the registrant must include in its
proxy statement a statement directing shareholders to refer to the registrant's or other soliciting
person's proxy statement for information required by Item 7 of this Schedule 14A with regard to the
registrant's or other soliciting person's nominee or nominees. The statement must explain to
shareholders that they can access the other soliciting person's proxy statement, and any other
relevant documents, without cost on the Commission's website.

Instruction to Item 7. The information disclosed pursuant to paragraph (d) of this Item
7will not be deemed incorporated by reference into any filing under the Securities Act of
1933 (15 U.S.C. 77a et seq.), the Securities Exchange Act of 1934 (15 U.S.C. 78a et seq.),
or the Investment Company Act of 1940 (15 U.S.C. 80a-1 et seq.), except to the extent that
the registrant specifically incorporates that information by reference.

Item 8. Compensation of directors and executive officers. Furnish the information required by Item
402 of Regulation S-K (§ 229.402 of this chapter) and paragraphs (e)(4) and (e)(5) of Item 407 of
Regulation S-K (§ 229.407(e)(4) and (e)(5) of this chapter) if action is to be taken with regard to:
(a) The election of directors;
(b) Any bonus, profit sharing or other compensation plan, contract or arrangement in which any
director, nominee for election as a director, or executive officer of the registrant will participate;
(c) Any pension or retirement plan in which any such person will participate; or
(d) The granting or extension to any such person of any options, warrants or rights to purchase any
securities, other than warrants or rights issued to security holders as such, on a pro rata basis.
However, if the solicitation is made on behalf of persons other than the registrant, the information
required need be furnished only as to nominees of the persons making the solicitation and
associates of such nominees. In the case of investment companies registered under the Investment
Company Act of 1940 (15 U.S.C. 80a), furnish the information required by Item 22(b)(13) of this
Schedule 14A.

Instruction. If an otherwise reportable compensation plan became subject to such requirements
because of an acquisition or merger and, within one year of the acquisition or merger, such plan was
terminated for purposes of prospective eligibility, the registrant may furnish a description of its
obligation to the designated individuals pursuant to the compensation plan. Such description may
be furnished in lieu of a description of the compensation plan in the proxy statement.

Item 9. Independent public accountants. If the solicitation is made on behalf of the registrant and
relates to: (1) The annual (or special meeting in lieu of annual) meeting of security holders at which
directors are to be elected, or a solicitation of consents or authorizations in lieu of such meeting or
(2) the election, approval or ratification of the registrant's accountant, furnish the following
information describing the registrant's relationship with its independent public accountant:
(a) The name of the principal accountant selected or being recommended to security holders for
election, approval or ratification for the current year. If no accountant has been selected or
recommended, so state and briefly describe the reasons therefor.
(b) The name of the principal accountant for the fiscal year most recently completed if different
from the accountant selected or recommended for the current year or if no accountant has yet been
selected or recommended for the current year.

(c) The proxy statement shall indicate: (1) Whether or not representatives of the principal
accountant for the current year and for the most recently completed fiscal year are expected to be
present at the security holders' meeting, (2) whether or not they will have the opportunity to make a
statement if they desire to do so, and (3) whether or not such representatives are expected to be
available to respond to appropriate questions.
(d) If during the registrant's two most recent fiscal years or any subsequent interim period, (1) an
independent accountant who was previously engaged as the principal accountant to audit the
registrant's financial statements, or an independent accountant on whom the principal accountant
expressed reliance in its report regarding a significant subsidiary, has resigned (or indicated it has
declined to stand for re-election after the completion of the current audit) or was dismissed, or (2) a
new independent accountant has been engaged as either the principal accountant to audit the
registrant's financial statements or as an independent accountant on whom the principal
accountant has expressed or is expected to express reliance in its report regarding a significant
subsidiary, then, notwithstanding any previous disclosure, provide the information required by Item
304(a) of Regulation S-K (§ 229.304 of this chapter).
(e)(1) Disclose, under the caption Audit Fees, the aggregate fees billed for each of the last two fiscal
years for professional services rendered by the principal accountant for the audit of the registrant's
annual financial statements and review of financial statements included in the registrant's Form 10Q (17 CFR 249.308a) or services that are normally provided by the accountant in connection with
statutory and regulatory filings or engagements for those fiscal years.
(2) Disclose, under the caption Audit-Related Fees, the aggregate fees billed in each of the last two
fiscal years for assurance and related services by the principal accountant that are reasonably
related to the performance of the audit or review of the registrant's financial statements and are not
reported under paragraph (e)(1) of this section. Registrants shall describe the nature of the services
comprising the fees disclosed under this category.
(3) Disclose, under the caption Tax Fees, the aggregate fees billed in each of the last two fiscal years
for professional services rendered by the principal accountant for tax compliance, tax advice, and
tax planning. Registrants shall describe the nature of the services comprising the fees disclosed
under this category.
(4) Disclose, under the caption All Other Fees, the aggregate fees billed in each of the last two fiscal
years for products and services provided by the principal accountant, other than the services
reported in paragraphs (e)(1) through (e)(3) of this section. Registrants shall describe the nature of
the services comprising the fees disclosed under this category.
(5)(i) Disclose the audit committee's pre-approval policies and procedures described in 17 CFR
210.2-01(c)(7)(i).
(ii) Disclose the percentage of services described in each of paragraphs (e)(2) through (e)(4) of this
section that were approved by the audit committee pursuant to 17 CFR 210.2-01(c)(7)(i)(C).
(6) If greater than 50 percent, disclose the percentage of hours expended on the principal
accountant's engagement to audit the registrant's financial statements for the most recent fiscal
year that were attributed to work performed by persons other than the principal accountant's fulltime, permanent employees.
(7) If the registrant is an investment company, disclose the aggregate non-audit fees billed by the
registrant's accountant for services rendered to the registrant, and to the registrant's investment
adviser (not including any subadviser whose role is primarily portfolio management and is
subcontracted with or overseen by another investment adviser), and any entity controlling,
controlled by, or under common control with the adviser that provides ongoing services to the
registrant for each of the last two fiscal years of the registrant.

(8) If the registrant is an investment company, disclose whether the audit committee of the board of
directors has considered whether the provision of non-audit services that were rendered to the
registrant's investment adviser (not including any subadviser whose role is primarily portfolio
management and is subcontracted with or overseen by another investment adviser), and any entity
controlling, controlled by, or under common control with the investment adviser that provides
ongoing services to the registrant that were not pre-approved pursuant to 17 CFR 210.2-01(c)(7)(ii)
is compatible with maintaining the principal accountant's independence.

Instruction to Item 9(e). For purposes of Item 9(e)(2), (3), and (4), registrants that are investment
companies must disclose fees billed for services rendered to the registrant and separately, disclose
fees required to be approved by the investment company registrant's audit committee pursuant to
17 CFR 210.2-01(c)(7)(ii). Registered investment companies must also disclose the fee percentages
as required by item 9(e)(5)(ii) for the registrant and separately, disclose the fee percentages as
required by item 9(e)(5)(ii) for the fees required to be approved by the investment company
registrant's audit committee pursuant to 17 CFR 210.2-01(c)(7)(ii).
Item 10. Compensation Plans. If action is to be taken with respect to any plan pursuant to which
cash or noncash compensation may be paid or distributed, furnish the following information:
(a) Plans subject to security holder action. (1) Describe briefly the material features of the plan being
acted upon, identify each class of persons who will be eligible to participate therein, indicate the
approximate number of persons in each such class, and state the basis of such participation.
(2)(i) In the tabular format specified below, disclose the benefits or amounts that will be received by
or allocated to each of the following under the plan being acted upon, if such benefits or amounts
are determinable:
New Plan Benefits

Plan name
Name and position

Dollar value ($)

Number of units

CEO
A
B
C
D
Executive Group
Non-Executive Director Group
Non-Executive Officer Employee Group

(ii) The table required by paragraph (a)(2)(i) of this Item shall provide information as to the following
persons:

(A) Each person (stating name and position) specified in paragraph (a)(3) of Item 402 of Regulation
S-K (§ 229.402(a)(3) of this chapter);

Instruction: In the case of investment companies registered under the Investment Company Act of
1940, furnish the information for Compensated Persons as defined in Item 22(b)(13) of this
Schedule in lieu of the persons specified in paragraph (a)(3) of Item 402 of Regulation S-K (§
229.402(a)(3) of this chapter).
(B) All current executive officers as a group;
(C) All current directors who are not executive officers as a group; and
(D) All employees, including all current officers who are not executive officers, as a group.

Instruction to New Plan Benefits Table
Additional columns should be added for each plan with respect to which security holder action is to
be taken.
(iii) If the benefits or amounts specified in paragraph (a)(2)(i) of this item are not determinable, state
the benefits or amounts which would have been received by or allocated to each of the following for
the last completed fiscal year if the plan had been in effect, if such benefits or amounts may be
determined, in the table specified in paragraph (a)(2)(i) of this Item:
(A) Each person (stating name and position) specified in paragraph (a)(3) of Item 402 of Regulation
S-K (§ 229.402(a)(3) of this chapter);
(B) All current executive officers as a group;
(C) All current directors who are not executive officers as a group; and
(D) All employees, including all current officers who are not executive officers, as a group.
(3) If the plan to be acted upon can be amended, otherwise than by a vote of security holders, to
increase the cost thereof to the registrant or to alter the allocation of the benefits as between the
persons and groups specified in paragraph (a)(2) of this item, state the nature of the amendments
which can be so made.
(b)(1) Additional information regarding specified plans subject to security holder action. With respect
to any pension or retirement plan submitted for security holder action, state:
(i) The approximate total amount necessary to fund the plan with respect to past services, the
period over which such amount is to be paid and the estimated annual payments necessary to pay
the total amount over such period; and
(ii) The estimated annual payment to be made with respect to current services. In the case of a
pension or retirement plan, information called for by paragraph (a)(2) of this Item may be furnished
in the format specified by paragraph (h)(2) of Item 402 of Regulation S-K (§ 229.402(h)(2) of this
chapter).

Instruction to paragraph (b)(1)(ii). In the case of investment companies registered under
the Investment Company Act of 1940 (15 U.S.C. 80a), refer to Instruction 4 in Item 22(b)
(13)(i) of this Schedule in lieu of paragraph (h)(2) of Item 402 of Regulation S-K (§
229.402(h)(2) of this chapter).
(2)(i) With respect to any specific grant of or any plan containing options, warrants or rights
submitted for security holder action, state:
(A) The title and amount of securities underlying such options, warrants or rights;
(B) The prices, expiration dates and other material conditions upon which the options, warrants or
rights may be exercised;
(C) The consideration received or to be received by the registrant or subsidiary for the granting or
extension of the options, warrants or rights;

(D) The market value of the securities underlying the options, warrants, or rights as of the latest
practicable date; and
(E) In the case of options, the federal income tax consequences of the issuance and exercise of
such options to the recipient and the registrant; and
(ii) State separately the amount of such options received or to be received by the following persons
if such benefits or amounts are determinable:
(A) Each person (stating name and position) specified in paragraph (a)(3) of Item 402 of Regulation
S-K (§ 229.402(a)(3) of this chapter);
(B) All current executive officers as a group;
(C) All current directors who are not executive officers as a group;
(D) Each nominee for election as a director;
(E) Each associate of any of such directors, executive officers or nominees;
(F) Each other person who received or is to receive 5 percent of such options, warrants or rights; and
(G) All employees, including all current officers who are not executive officers, as a group.
(c) Information regarding plans and other arrangements not subject to security holder action. Furnish
the information required by Item 201(d) of Regulation S-K (§ 229.201(d) of this chapter).

Instructions to paragraph (c). 1. If action is to be taken as described in paragraph (a) of
this Item with respect to the approval of a new compensation plan under which equity
securities of the registrant are authorized for issuance, information about the plan shall
be disclosed as required under paragraphs (a) and (b) of this Item and shall not be
included in the disclosure required by Item 201(d) of Regulation S-K (§ 229.201(d) of this
chapter). If action is to be taken as described in paragraph (a) of this Item with respect to
the amendment or modification of an existing plan under which equity securities of the
registrant are authorized for issuance, the registrant shall include information about
securities previously authorized for issuance under the plan (including any outstanding
options, warrants and rights previously granted pursuant to the plan and any securities
remaining available for future issuance under the plan) in the disclosure required by Item
201(d) of Regulation S-K (§ 229.201(d) of this chapter). Any additional securities that are
the subject of the amendments or modification of the existing plan shall be disclosed as
required under paragraphs (a) and (b) of this Item and shall not be included in the Item
201(d) disclosure.

Instructions
1. The term plan as used in this Item means any plan as defined in paragraph (a)(6)(ii) of Item 402 of
Regulation S-K (§ 229.402(a)(6)(ii) of this chapter).
2. If action is to be taken with respect to a material amendment or modification of an existing plan,
the item shall be answered with respect to the plan as proposed to be amended or modified and
shall indicate any material differences from the existing plan.
3. If the plan to be acted upon is set forth in a written document, three copies thereof shall be filed
with the Commission at the time copies of the proxy statement and form of proxy are first filed
pursuant to paragraph (a) or (b) of § 240.14a-6. Electronic filers shall file with the Commission a
copy of such written plan document in electronic format as an appendix to the proxy statement. It
need not be provided to security holders unless it is a part of the proxy statement.
4. Paragraph (b)(2)(ii) does not apply to warrants or rights to be issued to security holders as such
on a pro rata basis.

5. The Commission shall be informed, as supplemental information, when the proxy statement is
first filed, as to when the options, warrants or rights and the shares called for thereby will be
registered under the Securities Act or, if such registration is not contemplated, the section of the
Securities Act or rule of the Commission under which exemption from such registration is claimed
and the facts relied upon to make the exemption available.
Item 11. Authorization or issuance of securities otherwise than for exchange. If action is to be taken
with respect to the authorization or issuance of any securities otherwise than for exchange for
outstanding securities of the registrant, furnish the following information:
(a) State the title and amount of securities to be authorized or issued.
(b) Furnish the information required by Item 202 of Regulation S-K (§ 229.202 of this chapter). If the
terms of the securities cannot be stated or estimated with respect to any or all of the securities to
be authorized, because no offering thereof is contemplated in the proximate future, and if no further
authorization by security holders for the issuance thereof is to be obtained, it should be stated that
the terms of the securities to be authorized, including dividend or interest rates, conversion prices,
voting rights, redemption prices, maturity dates, and similar matters will be determined by the board
of directors. If the securities are additional shares of common stock of a class outstanding, the
description may be omitted except for a statement of the preemptive rights, if any. Where the
statutory provisions with respect to preemptive rights are so indefinite or complex that they cannot
be stated in summarized form, it will suffice to make a statement in the form of an opinion of
counsel as to the existence and extent of such rights.
(c) Describe briefly the transaction in which the securities are to be issued including a statement as
to (1) the nature and approximate amount of consideration received or to be received by the
registrant and (2) the approximate amount devoted to each purpose so far as determinable for
which the net proceeds have been or are to be used. If it is impracticable to describe the transaction
in which the securities are to be issued, state the reason, indicate the purpose of the authorization
of the securities, and state whether further authorization for the issuance of the securities by a vote
of security holders will be solicited prior to such issuance.
(d) If the securities are to be issued otherwise than in a public offering for cash, state the reasons
for the proposed authorization or issuance and the general effect thereof upon the rights of existing
security holders.
(e) Furnish the information required by Item 13(a) of this schedule.

Item 12. Modification or exchange of securities. If action is to be taken with respect to the
modification of any class of securities of the registrant, or the issuance or authorization for
issuance of securities of the registrant in exchange for outstanding securities of the registrant
furnish the following information:
(a) If outstanding securities are to be modified, state the title and amount thereof. If securities are to
be issued in exchange for outstanding securities, state the title and amount of securities to be so
issued, the title and amount of outstanding securities to be exchanged therefor and the basis of the
exchange.
(b) Describe any material differences between the outstanding securities and the modified or new
securities in respect of any of the matters concerning which information would be required in the
description of the securities in Item 202 of Regulation S-K (§ 229.202 of this chapter).
(c) State the reasons for the proposed modification or exchange and the general effect thereof upon
the rights of existing security holders.
(d) Furnish a brief statement as to arrears in dividends or as to defaults in principal or interest in
respect to the outstanding securities which are to be modified or exchanged and such other
information as may be appropriate in the particular case to disclose adequately the nature and
effect of the proposed action.

(e) Outline briefly any other material features of the proposed modification or exchange. If the plan
of proposed action is set forth in a written document, file copies thereof with the Commission in
accordance with § 240.14a-6.
(f) Furnish the information required by Item 13(a) of this Schedule.

Instruction. If the existing security is presently listed and registered on a national securities
exchange, state whether the registrant intends to apply for listing and registration of the new or
reclassified security on such exchange or any other exchange. If the registrant does not intend to
make such application, state the effect of the termination of such listing and registration.

Item 13. Financial and other information. (See Notes D and E at the beginning of this Schedule.)
(a) Information required. If action is to be taken with respect to any matter specified in Item 11 or 12,
furnish the following information:
(1) Financial statements meeting the requirements of Regulation S-X, including financial information
required by Rule 3-05 and Article 11 of Regulation S-X with respect to transactions other than
pursuant to which action is to be taken as described in this proxy statement (A smaller reporting
company may provide the information in Rules 8-04 and 8-05 of Regulation S-X (§§ 210.8-04 and
210.8-05 of this chapter) in lieu of the financial information required by Rule 3-05 and Article 11 of
Regulation S-X);
(2) Item 302 of Regulation S-K, supplementary financial information;
(3) Item 303 of Regulation S-K, management's discussion and analysis of financial condition and
results of operations;
(4) Item 304 of Regulation S-K, changes in and disagreements with accountants on accounting and
financial disclosure;
(5) Item 305 of Regulation S-K, quantitative and qualitative disclosures about market risk; and
(6) A statement as to whether or not representatives of the principal accountants for the current
year and for the most recently completed fiscal year:
(i) Are expected to be present at the security holders' meeting;
(ii) Will have the opportunity to make a statement if they desire to do so; and
(iii) Are expected to be available to respond to appropriate questions.
(b) Incorporation by reference. The information required pursuant to paragraph (a) of this Item may
be incorporated by reference into the proxy statement as follows:
(1) S-3 registrants and certain N-2 registrants. If the registrant meets the requirements of Form S-3 or
General Instruction A.2 of Form N-2 (see Note E to this Schedule), it may incorporate by reference to
previously-filed documents any of the information required by paragraph (a) of this Item, provided
that the requirements of paragraph (c) are met. Where the registrant meets the requirements of
Form S-3 or General Instruction A.2 of Form N-2 and has elected to furnish the required information
by incorporation by reference, the registrant may elect to update the information so incorporated by
reference to information in subsequently-filed documents.
(2) All registrants. The registrant may incorporate by reference any of the information required by
paragraph (a) of this Item, provided that the information is contained in an annual report to security
holders or a previously-filed statement or report, such report or statement is delivered to security
holders with the proxy statement and the requirements of paragraph (c) are met.
(c) Certain conditions applicable to incorporation by reference. Registrants eligible to incorporate by
reference into the proxy statement the information required by paragraph (a) of this Item in the
manner specified by paragraphs (b)(1) and (b)(2) may do so only if:
(1) The information is not required to be included in the proxy statement pursuant to the
requirement of another Item;
(2) The proxy statement identifies on the last page(s) the information incorporated by reference; and
(3) The material incorporated by reference substantially meets the requirements of this Item or the
appropriate portions of this Item.

Instructions to Item 13. 1. Notwithstanding the provisions of this Item, any or all of the information
required by paragraph (a) of this Item not material for the exercise of prudent judgment in regard to
the matter to be acted upon may be omitted. In the usual case the information is deemed material
to the exercise of prudent judgment where the matter to be acted upon is the authorization or
issuance of a material amount of senior securities, but the information is not deemed material
where the matter to be acted upon is the authorization or issuance of common stock, otherwise
than in an exchange, merger, consolidation, acquisition or similar transaction, the authorization of
preferred stock without present intent to issue or the authorization of preferred stock for issuance
for cash in an amount constituting fair value.
2. In order to facilitate compliance with Rule 2-02(a) of Regulation S-X, one copy of the definitive
proxy statement filed with the Commission shall include a manually signed copy of the accountant's
report. If the financial statements are incorporated by reference, a manually signed copy of the
accountant's report shall be filed with the definitive proxy statement.
3. Notwithstanding the provisions of Regulation S-X, no schedules other than those prepared in
accordance with Rules 12-15, 12-28 and 12-29 (or, for management investment companies, Rules
12-12 through 12-14) of that regulation need be furnished in the proxy statement.
4. Unless registered on a national securities exchange or otherwise required to furnish such
information, registered investment companies need not furnish the information required by
paragraph (a)(2) or (3) of this Item.
5. If the registrant submits preliminary proxy material incorporating by reference financial
statements required by this Item, the registrant should furnish a draft of the financial statements if
the document from which they are incorporated has not been filed with or furnished to the
Commission.
6. A registered investment company need not comply with items (a)(2), (a)(3), and (a)(5) of this Item
13.

Item 14. Mergers, consolidations, acquisitions and similar matters. (See Notes A and D at the
beginning of this Schedule)

Instructions to Item 14: 1. In transactions in which the consideration offered to security holders
consists wholly or in part of securities registered under the Securities Act of 1933, furnish the
information required by Form S-4 (§ 239.25 of this chapter), Form F-4 (§ 239.34 of this chapter), or
Form N-14 (§ 239.23 of this chapter), as applicable, instead of this Item. Only a Form S-4, Form F-4,
or Form N-14 must be filed in accordance with § 240.14a-6(j).
2. (a) In transactions in which the consideration offered to security holders consists wholly of cash,
the information required by paragraph (c)(1) of this Item for the acquiring company need not be
provided unless the information is material to an informed voting decision (e.g., the security holders
of the target company are voting and financing is not assured).
(b) Additionally, if only the security holders of the target company are voting:
i. The financial information in paragraphs (b)(8)-(11) of this Item for the acquiring company and the
target need not be provided; and
ii. The information in paragraph (c)(2) of this Item for the target company need not be provided.
If, however, the transaction is a going-private transaction (as defined by § 240.13e-3), then the
information required by paragraph (c)(2) of this Item must be provided and to the extent that the
going-private rules require the information specified in paragraph (b)(8)-(b)(11) of this Item, that
information must be provided as well.
3. In transactions in which the consideration offered to security holders consists wholly of securities
exempt from registration under the Securities Act of 1933 or a combination of exempt securities
and cash, information about the acquiring company required by paragraph (c)(1) of this Item need
not be provided if only the security holders of the acquiring company are voting, unless the
information is material to an informed voting decision. If only the security holders of the target

company are voting, information about the target company in paragraph (c)(2) of this Item need not
be provided. However, the information required by paragraph (c)(2) of this Item must be provided if
the transaction is a going-private (as defined by § 240.13e-3) or roll-up (as described by Item 901 of
Regulation S-K (§ 229.901 of this chapter)) transaction.
4. The information required by paragraphs (b)(8)-(11) and (c) need not be provided if the plan being
voted on involves only the acquiring company and one or more of its totally held subsidiaries and
does not involve a liquidation or a spin off.
5. To facilitate compliance with Rule 2-02(a) of Regulation S-X (§ 210.2-02(a) of this chapter)
(technical requirements relating to accountants' reports), one copy of the definitive proxy statement
filed with the Commission must include a signed copy of the accountant's report. If the financial
statements are incorporated by reference, a signed copy of the accountant's report must be filed
with the definitive proxy statement. Signatures may be typed if the document is filed electronically
on EDGAR. See Rule 302 of Regulation S-T (§ 232.302 of this chapter).
6. Notwithstanding the provisions of Regulation S-X, no schedules other than those prepared in
accordance with § 210.12-15, § 210.12-28 and § 210.12-29 of this chapter (or, for management
investment companies, §§ 210.12-12 through 210.12-14 of this chapter) of that regulation need be
furnished in the proxy statement.
7. If the preliminary proxy material incorporates by reference financial statements required by this
Item, a draft of the financial statements must be furnished to the Commission staff upon request if
the document from which they are incorporated has not been filed with or furnished to the
Commission.
(a) Applicability. If action is to be taken with respect to any of the following transactions, provide the
information required by this Item:
(1) A merger or consolidation;
(2) An acquisition of securities of another person;
(3) An acquisition of any other going business or the assets of a going business;
(4) A sale or other transfer of all or any substantial part of assets; or
(5) A liquidation or dissolution.
(b) Transaction information. Provide the following information for each of the parties to the
transaction unless otherwise specified:
(1) Summary term sheet. The information required by Item 1001 of Regulation M-A (§ 229.1001 of
this chapter).
(2) Contact information. The name, complete mailing address and telephone number of the principal
executive offices.
(3) Business conducted. A brief description of the general nature of the business conducted.
(4) Terms of the transaction. The information required by Item 1004(a)(2) of Regulation M-A (§
229.1004 of this chapter).
(5) Regulatory approvals. A statement as to whether any federal or state regulatory requirements
must be complied with or approval must be obtained in connection with the transaction and, if so,
the status of the compliance or approval.
(6) Reports, opinions, appraisals. If a report, opinion or appraisal materially relating to the transaction
has been received from an outside party, and is referred to in the proxy statement, furnish the
information required by Item 1015(b) of Regulation M-A (§ 229.1015 of this chapter).
(7) Past contacts, transactions or negotiations. The information required by Items 1005(b) and
1011(a)(1) of Regulation M-A (§ 229.1005 of this chapter and § 229.1011 of this chapter), for the
parties to the transaction and their affiliates during the periods for which financial statements are
presented or incorporated by reference under this Item.
(8)—(10) [Reserved]

(11) Financial information. If material, financial information required by Article 11 of Regulation S-X
(§§ 210.10-01 through 229.11-03 of this chapter) with respect to this transaction.

Instructions to paragraph (b)(11): 1. Present any Article 11 information required with
respect to transactions other than those being voted upon (where not incorporated by
reference) together with the pro forma information relating to the transaction being voted
upon. In presenting this information, you must clearly distinguish between the transaction
being voted upon and any other transaction.
2. If current pro forma financial information with respect to all other transactions is
incorporated by reference, you need only present the pro forma effect of this
transaction.

(c) Information about the parties to the transaction—(1) Acquiring company. Furnish the information
required by Part B (Registrant Information) of Form S-4 (§ 239.25 of this chapter) or Form F-4 (§
239.34 of this chapter), as applicable, for the acquiring company. However, financial statements
need only be presented for the latest two fiscal years and interim periods.
(2) Acquired company. Furnish the information required by Part C (Information with Respect to the
Company Being Acquired) of Form S-4 (§ 239.25 of this chapter) or Form F-4 (§ 239.34 of this
chapter), as applicable.
(d) Information about parties to the transaction: registered investment companies and business

development companies. If the acquiring company or the acquired company is an investment
company registered under the Investment Company Act of 1940 or a business development
company as defined by Section 2(a)(48) of the Investment Company Act of 1940, provide the
following information for that company instead of the information specified by paragraph (c) of this
Item:
(1) Information required by Item 101 of Regulation S-K (§ 229.101 of this chapter), description of
business;
(2) Information required by Item 102 of Regulation S-K (§ 229.102 of this chapter), description of
property;
(3) Information required by Item 103 of Regulation S-K (§ 229.103 of this chapter), legal
proceedings;
(4) Information required by Item 201(a), (b) and (c) of Regulation S-K (§ 229.201(a), (b) and (c) of
this chapter), market price of and dividends on the registrant's common equity and related
stockholder matters;
(5) Financial statements meeting the requirements of Regulation S-X, including financial information
required by Rule 3-05 and Article 11 of Regulation S-X (§ 210.3-05 and § 210.11-01 through §
210.11-03 of this chapter) with respect to transactions other than that as to which action is to be
taken as described in this proxy statement;
(6) [Reserved]
(7) Information required by Item 302 of Regulation S-K (§ 229.302 of this chapter), supplementary
financial information;
(8) Information required by Item 303 of Regulation S-K (§ 229.303 of this chapter), management's
discussion and analysis of financial condition and results of operations; and
(9) Information required by Item 304 of Regulation S-K (§ 229.304 of this chapter), changes in and
disagreements with accountants on accounting and financial disclosure.

Instruction to paragraph (d) of Item 14: Unless registered on a national securities
exchange or otherwise required to furnish such information, registered investment

companies need not furnish the information required by paragraphs (d)(6), (d)(7) and (d)
(8) of this Item.
(e) Incorporation by reference. (1) The information required by paragraph (c) of this section may be
incorporated by reference into the proxy statement to the same extent as would be permitted by
Form S-4 (§ 239.25 of this chapter) or Form F-4 (§ 239.34 of this chapter), as applicable.
(2) Alternatively, the registrant may incorporate by reference into the proxy statement the
information required by paragraph (c) of this Item if it is contained in an annual report sent to
security holders in accordance with § 240.14a-3 of this chapter with respect to the same meeting or
solicitation of consents or authorizations that the proxy statement relates to and the information
substantially meets the disclosure requirements of Item 14 or Item 17 of Form S-4 (§ 239.25 of this
chapter) or Form F-4 (§ 239.34 of this chapter), as applicable.
(f) De-SPAC transactions. (1) If the transaction is a de-SPAC transaction, as defined in § 229.1601(a)
(Item 1601(a) of Regulation S-K), then the disclosure provisions of §§ 229.1603, 229.1604(b)(1)
through (6) and (c), 229.1605 through 229.1607, and 229.1609 (Items 1603, 1604(b)(1) through (6)
and (c), 1605 through 1607, and 1609 of Regulation S-K) apply in addition to the provisions of this
schedule and disclosure thereunder must be provided in the proxy statement, and the structured
data provisions of § 229.1610 (Item 1610 of Regulation S-K) apply to those disclosures. The
information required by § 229.1604(b)(1) through (6) must be briefly described in the front of the
disclosure document. To the extent that the applicable disclosure requirements of subpart 229.1600
of Regulation S-K are inconsistent with the disclosure requirements of this schedule, the
requirements of subpart 229.1600 are controlling.
(2) Provide the following additional information for the target company:
(i) Information required by § 229.101 (Item 101 of Regulation S-K, description of business);
(ii) Information required by § 229.102 (Item 102 of Regulation S-K, description of property);
(iii) Information required by § 229.103 (Item 103 of Regulation S-K, legal proceedings);
(iv) Information required by § 229.304 (Item 304 of Regulation S-K, changes in and disagreements
with accountants on accounting and financial disclosure);
(v) Information required by § 229.403 (Item 403 of Regulation S-K, security ownership of certain
beneficial owners and management), assuming the completion of the de-SPAC transaction and any
related financing transaction; and
(vi) Information required by § 229.701 (Item 701 of Regulation S-K, recent sales of unregistered
securities).

Item 15. Acquisition or disposition of property. If action is to be taken with respect to the acquisition
or disposition of any property, furnish the following information:
(a) Describe briefly the general character and location of the property.
(b) State the nature and amount of consideration to be paid or received by the registrant or any
subsidiary. To the extent practicable, outline briefly the facts bearing upon the question of the
fairness of the consideration.
(c) State the name and address of the transferer or transferee, as the case may be and the nature of
any material relationship of such person to the registrant or any affiliate of the registrant.
(d) Outline briefly any other material features of the contract or transaction.

Item 16. Restatement of accounts. If action is to be taken with respect to the restatement of any
asset, capital, or surplus account of the registrant furnish the following information:
(a) State the nature of the restatement and the date as of which it is to be effective.
(b) Outline briefly the reasons for the restatement and for the selection of the particular effective
date.

(c) State the name and amount of each account (including any reserve accounts) affected by the
restatement and the effect of the restatement thereon. Tabular presentation of the amounts shall be
made when appropriate, particularly in the case of recapitalizations.
(d) To the extent practicable, state whether and the extent, if any, to which, the restatement will, as
of the date thereof, alter the amount available for distribution to the holders of equity securities.
Item 17. Action with respect to reports. If action is to be taken with respect to any report of the
registrant or of its directors, officers or committees or any minutes of a meeting of its security
holders, furnish the following information:
(a) State whether or not such action is to constitute approval or disapproval of any of the matters
referred to in such reports or minutes.
(b) Identify each of such matters which it is intended will be approved or disapproved, and furnish
the information required by the appropriate item or items of this schedule with respect to each such
matter.

Item 18. Matters not required to be submitted. If action is to be taken with respect to any matter
which is not required to be submitted to a vote of security holders, state the nature of such matter,
the reasons for submitting it to a vote of security holders and what action is intended to be taken by
the registrant in the event of a negative vote on the matter by the security holders.

Item 19. Amendment of character, bylaws or other documents. If action is to be taken with respect to
any amendment of the registrant's charter, bylaws or other documents as to which information is
not required above, state briefly the reasons for and the general effect of such amendment.

Instructions. 1. Where the matter to be acted upon is the classification of directors, state whether
vacancies which occur during the year may be filled by the board of directors to serve only until the
next annual meeting or may be so filled for the remainder of the full term.
2. Attention is directed to the discussion of disclosure regarding anti-takeover and similar proposals
in Release No. 34-15230 (October 13, 1978).

Item 20. Other proposed action. If action is to be taken on any matter not specifically referred to in
this Schedule 14A, describe briefly the substance of each such matter in substantially the same
degree of detail as is required by Items 5 to 19, inclusive, of this Schedule, and, with respect to
investment companies registered under the Investment Company Act of 1940, Item 22 of this
Schedule. Registrants required to provide a separate shareholder vote pursuant to section 111(e)(1)
of the Emergency Economic Stabilization Act of 2008 (12 U.S.C. 5221(e)(1)) and § 240.14a-20 shall
disclose that they are providing such a vote as required pursuant to the Emergency Economic
Stabilization Act of 2008, and briefly explain the general effect of the vote, such as whether the vote
is non-binding.

Item 21. Voting procedures. As to each matter which is to be submitted to a vote of security holders,
furnish the following information:
(a) State the vote required for approval or election, other than for the approval of auditors.
(b) Disclose the method by which votes will be counted, including the treatment and effect under
applicable state law and registrant charter and bylaw provisions of abstentions, broker non-votes,
and, to the extent applicable, a security holder's withholding of authority to vote for a nominee in an
election of directors.
(c) When applicable, disclose how the soliciting person intends to treat proxy authority granted in
favor of any other soliciting person's nominees if such other soliciting person abandons its
solicitation or fails to comply with § 240.14a-19.

Item 22. Information required in investment company proxy statement. (a) General.
(1) Definitions. Unless the context otherwise requires, terms used in this Item that are defined in §
240.14a-1 (with respect to proxy soliciting material), in § 240.14c-1 (with respect to information
statements), and in the Investment Company Act of 1940 shall have the same meanings provided
therein and the following terms shall also apply:

(i) Administrator. The term “Administrator” shall mean any person who provides significant
administrative or business affairs management services to a Fund.
(ii) Affiliated broker. The term “Affiliated Broker” shall mean any broker:
(A) That is an affiliated person of the Fund;
(B) That is an affiliated person of such person; or
(C) An affiliated person of which is an affiliated person of the Fund, its investment adviser, principal
underwriter, or Administrator.
(iii) Distribution plan. The term “Distribution Plan” shall mean a plan adopted pursuant to Rule 12b-1
under the Investment Company Act of 1940 (§ 270.12b-1 of this chapter).
(iv) Family of Investment Companies. The term “Family of Investment Companies” shall mean any
two or more registered investment companies that:
(A) Share the same investment adviser or principal underwriter; and
(B) Hold themselves out to investors as related companies for purposes of investment and investor
services.
(v) Fund. The term “Fund” shall mean a Registrant or, where the Registrant is a series company, a
separate portfolio of the Registrant.
(vi) Fund complex. The term “Fund Complex” shall mean two or more Funds that:
(A) Hold themselves out to investors as related companies for purposes of investment and investor
services; or
(B) Have a common investment adviser or have an investment adviser that is an affiliated person of
the investment adviser of any of the other Funds.
(vii) Immediate Family Member. The term “Immediate Family Member” shall mean a person's spouse;
child residing in the person's household (including step and adoptive children); and any dependent
of the person, as defined in section 152 of the Internal Revenue Code (26 U.S.C. 152).
(viii) Officer. The term “Officer” shall mean the president, vice-president, secretary, treasurer,
controller, or any other officer who performs policy-making functions.
(ix) Parent. The term “Parent” shall mean the affiliated person of a specified person who controls the
specified person directly or indirectly through one or more intermediaries.
(x) Registrant. The term “Registrant” shall mean an investment company registered under the
Investment Company Act of 1940 (15 U.S.C. 80a) or a business development company as defined
by section 2(a)(48) of the Investment Company Act of 1940 (15 U.S.C. 80a-2(a)(48)).
(xi) Sponsoring Insurance Company. The term “Sponsoring Insurance Company” of a Fund that is a
separate account shall mean the insurance company that establishes and maintains the separate
account and that owns the assets of the separate account.
(xii) Subsidiary. The term “Subsidiary” shall mean an affiliated person of a specified person who is
controlled by the specified person directly, or indirectly through one or more intermediaries.
(2) [Reserved]
(3) General disclosure. Furnish the following information in the proxy statement of a Fund or Funds:
(i) State the name and address of the Fund's investment adviser, principal underwriter, and
Administrator.
(ii) When a Fund proxy statement solicits a vote on proposals affecting more than one Fund or class
of securities of a Fund (unless the proposal or proposals are the same and affect all Fund or class
shareholders), present a summary of all of the proposals in tabular form on one of the first three
pages of the proxy statement and indicate which Fund or class shareholders are solicited with
respect to each proposal.
(iii) Unless the proxy statement is accompanied by a copy of the Fund's most recent annual report,
state prominently in the proxy statement that the Fund will furnish, without charge, a copy of the
annual report and the most recent semi-annual report succeeding the annual report, if any, to a
shareholder upon request, providing the name, address, and toll-free telephone number of the

person to whom such request shall be directed (or, if no toll-free telephone number is provided, a
self-addressed postage paid card for requesting the annual report). The Fund should provide a copy
of the annual report and the most recent semi-annual report succeeding the annual report, if any, to
the requesting shareholder by first class mail, or other means designed to assure prompt delivery,
within three business days of the request.
(iv) If the action to be taken would, directly or indirectly, establish a new fee or expense or increase
any existing fee or expense to be paid by the Fund or its shareholders, provide a table showing the
current and pro forma fees (with the required examples) using the format prescribed in the
appropriate registration statement form under the Investment Company Act of 1940 (for open-end
management investment companies, Item 3 of Form N-1A (§ 239.15A); for closed-end management
investment companies, Item 3 of Form N-2 (§ 239.14); and for separate accounts that offer variable
annuity contracts, Item 4 of Form N-3 (§ 239.17a)).

Instructions. 1. Where approval is sought only for a change in asset breakpoints for a pre-existing
fee that would not have increased the fee for the previous year (or have the effect of increasing fees
or expenses, but for any other reason would not be reflected in a pro forma fee table), describe the
likely effect of the change in lieu of providing pro forma fee information.
2. An action would indirectly establish or increase a fee or expense where, for example, the approval
of a new investment advisory contract would result in higher custodial or transfer agency fees.
3. The tables should be prepared in a manner designed to facilitate understanding of the impact of
any change in fees or expenses.
4. A Fund that offers its shares exclusively to one or more separate accounts and thus is not
required to include a fee table in its prospectus (see Item 3 of Form N-1A (§ 239.15A)) should
nonetheless prepare a table showing current and pro forma expenses and disclose that the table
does not reflect separate account expenses, including sales load.
(v) If action is to be taken with respect to the election of directors or the approval of an advisory
contract, describe any purchases or sales of securities of the investment adviser or its Parents, or
Subsidiaries of either, since the beginning of the most recently completed fiscal year by any director
or any nominee for election as a director of the Fund.

Instructions. 1. Identify the parties, state the consideration, the terms of payment and describe any
arrangement or understanding with respect to the composition of the board of directors of the Fund
or of the investment adviser, or with respect to the selection of appointment of any person to any
office with either such company.
2. Transactions involving securities in an amount not exceeding one percent of the outstanding
securities of any class of the investment adviser or any of its Parents or Subsidiaries may be
omitted.
(b) Election of Directors. If action is to be taken with respect to the election of directors of a Fund,
furnish the following information in the proxy statement in addition to, in the case of business
development companies, the information (and in the format) required by Item 7 and Item 8 of this
Schedule 14A.

Instructions to introductory text of paragraph (b). 1. Furnish information with respect to
a prospective investment adviser to the extent applicable.
2. If the solicitation is made by or on behalf of a person other than the Fund or an
investment adviser of the Fund, provide information only as to nominees of the person
making the solicitation.
3. When providing information about directors and nominees for election as directors in
response to this Item 22(b), furnish information for directors or nominees who are or
would be “interested persons” of the Fund within the meaning of section 2(a)(19) of the
Investment Company Act of 1940 (15 U.S.C. 80a-2(a)(19)) separately from the

information for directors or nominees who are not or would not be interested persons of
the Fund. For example, when furnishing information in a table, you should provide
separate tables (or separate sections of a single table) for directors and nominees who
are or would be interested persons and for directors or nominees who are not or would
not be interested persons. When furnishing information in narrative form, indicate by
heading or otherwise the directors or nominees who are or would be interested persons
and the directors or nominees who are not or would not be interested persons.
4. No information need be given about any director whose term of office as a director
will not continue after the meeting to which the proxy statement relates.
(1) Provide the information required by the following table for each director, nominee for
election as director, Officer of the Fund, person chosen to become an Officer of the Fund,
and, if the Fund has an advisory board, member of the board. Explain in a footnote to the
table any family relationship between the persons listed.

(1)

(2)

(3)

(4)

(5)

(6)

Name,

Position(s)

Term

Principal

Number of

Other

Address,

Held with

of

Occupation(s)

Portfolios

Directorships

and Age

Fund

Office

During Past 5

in Fund

Held by

and

Years

Complex

Director or

Length

Overseen

Nominee for

of Time

by Director

Director

Served

or
Nominee
for Director

Instructions to paragraph (b)(1). 1. For purposes of this paragraph, the term “family
relationship” means any relationship by blood, marriage, or adoption, not more remote
than first cousin.
2. No nominee or person chosen to become a director or Officer who has not consented
to act as such may be named in response to this Item. In this regard, see Rule 14a-4(d)
under the Exchange Act (§ 240.14a-4(d)).
3. If fewer nominees are named than the number fixed by or pursuant to the governing
instruments, state the reasons for this procedure and that the proxies cannot be voted
for a greater number of persons than the number of nominees named.
4. For each director or nominee for election as director who is or would be an “interested
person” of the Fund within the meaning of section 2(a)(19) of the Investment Company
Act of 1940 (15 U.S.C. 80a-2(a)(19)), describe, in a footnote or otherwise, the
relationship, events, or transactions by reason of which the director or nominee is or
would be an interested person.
5. State the principal business of any company listed under column (4) unless the
principal business is implicit in its name.

6. Include in column (5) the total number of separate portfolios that a nominee for
election as director would oversee if he were elected.
7. Indicate in column (6) directorships not included in column (5) that are held by a
director or nominee for election as director in any company with a class of securities
registered pursuant to section 12 of the Exchange Act (15 U.S.C. 78l), or subject to the
requirements of section 15(d) of the Exchange Act (15 U.S.C. 78o(d)), or any company
registered as an investment company under the Investment Company Act of 1940, (15
U.S.C. 80a), as amended, and name the companies in which the directorships are held.
Where the other directorships include directorships overseeing two or more portfolios in
the same Fund Complex, identify the Fund Complex and provide the number of
portfolios overseen as a director in the Fund Complex rather than listing each portfolio
separately.

(2) For each individual listed in column (1) of the table required by paragraph (b)(1) of this Item,
except for any director or nominee for election as director who is not or would not be an “interested
person” of the Fund within the meaning of section 2(a)(19) of the Investment Company Act of 1940
(15 U.S.C. 80a-2(a)(19)), describe any positions, including as an officer, employee, director, or
general partner, held with affiliated persons or principal underwriters of the Fund.

Instruction to paragraph (b)(2). When an individual holds the same position(s) with two
or more registered investment companies that are part of the same Fund Complex,
identify the Fund Complex and provide the number of registered investment companies
for which the position(s) are held rather than listing each registered investment company
separately.
(3)(i) For each director or nominee for election as director, briefly discuss the specific experience,
qualifications, attributes, or skills that led to the conclusion that the person should serve as a
director for the Fund at the time that the disclosure is made in light of the Fund's business and
structure. If material, this disclosure should cover more than the past five years, including
information about the person's particular areas of expertise or other relevant qualifications.
(ii) Describe briefly any arrangement or understanding between any director, nominee for election as
director, Officer, or person chosen to become an Officer, and any other person(s) (naming the
person(s)) pursuant to which he was or is to be selected as a director, nominee, or Officer.

Instruction to paragraph (b)(3)(ii). Do not include arrangements or understandings with
directors or Officers acting solely in their capacities as such.
(4)(i) Unless disclosed in the table required by paragraph (b)(1) of this Item, describe any positions,
including as an officer, employee, director, or general partner, held by any director or nominee for
election as director, who is not or would not be an “interested person” of the Fund within the
meaning of section 2(a)(19) of the Investment Company Act of 1940 (15 U.S.C. 80a-2(a)(19)), or
Immediate Family Member of the director or nominee, during the past five years, with:
(A) The Fund;
(B) An investment company, or a person that would be an investment company but for the
exclusions provided by sections 3(c)(1) and 3(c)(7) of the Investment Company Act of 1940 (15
U.S.C. 80a-3(c)(1) and (c)(7)), having the same investment adviser, principal underwriter, or
Sponsoring Insurance Company as the Fund or having an investment adviser, principal underwriter,

or Sponsoring Insurance Company that directly or indirectly controls, is controlled by, or is under
common control with an investment adviser, principal underwriter, or Sponsoring Insurance
Company of the Fund;
(C) An investment adviser, principal underwriter, Sponsoring Insurance Company, or affiliated person
of the Fund; or
(D) Any person directly or indirectly controlling, controlled by, or under common control with an
investment adviser, principal underwriter, or Sponsoring Insurance Company of the Fund.
(ii) Unless disclosed in the table required by paragraph (b)(1) of this Item or in response to
paragraph (b)(4)(i) of this Item, indicate any directorships held during the past five years by each
director or nominee for election as director in any company with a class of securities registered
pursuant to section 12 of the Exchange Act (15 U.S.C. 78l) or subject to the requirements of section
15(d) of the Exchange Act (15 U.S.C. 78o(d)) or any company registered as an investment company
under the Investment Company Act of 1940 (15 U.S.C. 80a-1 et seq.), as amended, and name the
companies in which the directorships were held.

Instruction to paragraph (b)(4). When an individual holds the same position(s) with two
or more portfolios that are part of the same Fund Complex, identify the Fund Complex and
provide the number of portfolios for which the position(s) are held rather than listing each
portfolio separately.
(5) For each director or nominee for election as director, state the dollar range of equity securities
beneficially owned by the director or nominee as required by the following table:
(i) In the Fund; and
(ii) On an aggregate basis, in any registered investment companies overseen or to be overseen by
the director or nominee within the same Family of Investment Companies as the Fund.

(1)

(2)

(3)

Name of

Dollar Range of

Aggregate Dollar Range of Equity Securities in

Director or

Equity Securities in

All Funds Overseen or to be Overseen by

Nominee

the Fund

Director or Nominee in Family of Investment
Companies

Instructions to paragraph (b)(5). 1. Information should be provided as of the most recent
practicable date. Specify the valuation date by footnote or otherwise.
2. Determine “beneficial ownership” in accordance with rule 16a-1(a)(2) under the Exchange
Act (§ 240.16a-1(a)(2)).
3. If action is to be taken with respect to more than one Fund, disclose in column (2) the
dollar range of equity securities beneficially owned by a director or nominee in each such
Fund overseen or to be overseen by the director or nominee.
4. In disclosing the dollar range of equity securities beneficially owned by a director or
nominee in columns (2) and (3), use the following ranges: none, $1-$10,000,
$10,001-$50,000, $50,001-$100,000, or over $100,000.

(6) For each director or nominee for election as director who is not or would not be an “interested person” of
the Fund within the meaning of section 2(a)(19) of the Investment Company Act of 1940 (15 U.S.C. 80a-2(a)
(19), and his Immediate Family Members, furnish the information required by the following table as to each
class of securities owned beneficially or of record in:
(i) An investment adviser, principal underwriter, or Sponsoring Insurance Company of the Fund; or
(ii) A person (other than a registered investment company) directly or indirectly controlling, controlled by, or
under common control with an investment adviser, principal underwriter, or Sponsoring Insurance Company of
the Fund:

(1)

(2)

(3)

(4)

(5)

(6)

Name of

Name of Owners and

Company

Title of

Value of

Percent

Director or

Relationships to

Class

Securities

of Class

Nominee

Director or Nominee

Instructions to paragraph (b)(6). 1. Information should be provided as of the most recent
practicable date. Specify the valuation date by footnote or otherwise.
2. An individual is a “beneficial owner” of a security if he is a “beneficial owner” under either
rule 13d-3 or rule 16a-1(a)(2) under the Exchange Act (§§ 240.13d-3 or 240.16a-1(a)(2)).
3. Identify the company in which the director, nominee, or Immediate Family Member of the
director or nominee owns securities in column (3). When the company is a person directly or
indirectly controlling, controlled by, or under common control with an investment adviser,
principal underwriter, or Sponsoring Insurance Company, describe the company's
relationship with the investment adviser, principal underwriter, or Sponsoring Insurance
Company.
4. Provide the information required by columns (5) and (6) on an aggregate basis for each
director (or nominee) and his Immediate Family Members.

(7) Unless disclosed in response to paragraph (b)(6) of this Item, describe any direct or indirect interest, the
value of which exceeds $120,000, of each director or nominee for election as director who is not or would not
be an “interested person” of the Fund within the meaning of section 2(a)(19) of the Investment Company Act
of 1940 (15 U.S.C. 80a-2(a)(19)), or Immediate Family Member of the director or nominee, during the past five
years, in:
(i) An investment adviser, principal underwriter, or Sponsoring Insurance Company of the Fund; or
(ii) A person (other than a registered investment company) directly or indirectly controlling, controlled by, or
under common control with an investment adviser, principal underwriter, or Sponsoring Insurance Company of
the Fund.

Instructions to paragraph (b)(7). 1. A director, nominee, or Immediate Family Member has an
interest in a company if he is a party to a contract, arrangement, or understanding with respect

to any securities of, or interest in, the company.
2. The interest of the director (or nominee) and the interests of his Immediate Family
Members should be aggregated in determining whether the value exceeds $120,000.

(8) Describe briefly any material interest, direct or indirect, of any director or nominee for election as director
who is not or would not be an “interested person” of the Fund within the meaning of section 2(a)(19) of the
Investment Company Act of 1940 (15 U.S.C. 80a-2(a)(19)), or Immediate Family Member of the director or
nominee, in any transaction, or series of similar transactions, since the beginning of the last two completed
fiscal years of the Fund, or in any currently proposed transaction, or series of similar transactions, in which the
amount involved exceeds $120,000 and to which any of the following persons was or is to be a party:
(i) The Fund;
(ii) An Officer of the Fund;
(iii) An investment company, or a person that would be an investment company but for the exclusions
provided by sections 3(c)(1) and 3(c)(7) of the Investment Company Act of 1940 (15 U.S.C. 80a-3(c)(1) and
(c)(7)), having the same investment adviser, principal underwriter, or Sponsoring Insurance Company as the
Fund or having an investment adviser, principal underwriter, or Sponsoring Insurance Company that directly or
indirectly controls, is controlled by, or is under common control with an investment adviser, principal
underwriter, or Sponsoring Insurance Company of the Fund;
(iv) An Officer of an investment company, or a person that would be an investment company but for the
exclusions provided by sections 3(c)(1) and 3(c)(7) of the Investment Company Act of 1940 (15 U.S.C. 80a3(c)(1) and (c)(7)), having the same investment adviser, principal underwriter, or Sponsoring Insurance
Company as the Fund or having an investment adviser, principal underwriter, or Sponsoring Insurance
Company that directly or indirectly controls, is controlled by, or is under common control with an investment
adviser, principal underwriter, or Sponsoring Insurance Company of the Fund;
(v) An investment adviser, principal underwriter, or Sponsoring Insurance Company of the Fund;
(vi) An Officer of an investment adviser, principal underwriter, or Sponsoring Insurance Company of the Fund;
(vii) A person directly or indirectly controlling, controlled by, or under common control with an investment
adviser, principal underwriter, or Sponsoring Insurance Company of the Fund; or
(viii) An Officer of a person directly or indirectly controlling, controlled by, or under common control with an
investment adviser, principal underwriter, or Sponsoring Insurance Company of the Fund.

Instructions to paragraph (b)(8). 1. Include the name of each director, nominee, or Immediate
Family Member whose interest in any transaction or series of similar transactions is described
and the nature of the circumstances by reason of which the interest is required to be
described.
2. State the nature of the interest, the approximate dollar amount involved in the transaction,
and, where practicable, the approximate dollar amount of the interest.
3. In computing the amount involved in the transaction or series of similar transactions,
include all periodic payments in the case of any lease or other agreement providing for
periodic payments.

4. Compute the amount of the interest of any director, nominee, or Immediate Family
Member of the director or nominee without regard to the amount of profit or loss involved in
the transaction(s).
5. As to any transaction involving the purchase or sale of assets, state the cost of the assets
to the purchaser and, if acquired by the seller within two years prior to the transaction, the
cost to the seller. Describe the method used in determining the purchase or sale price and
the name of the person making the determination.
6. If the proxy statement relates to multiple portfolios of a series Fund with different fiscal
years, then, in determining the date that is the beginning of the last two completed fiscal
years of the Fund, use the earliest date of any series covered by the proxy statement.
7. Disclose indirect, as well as direct, material interests in transactions. A person who has a
position or relationship with, or interest in, a company that engages in a transaction with one
of the persons listed in paragraphs (b)(8)(i) through (b)(8)(viii) of this Item may have an
indirect interest in the transaction by reason of the position, relationship, or interest. The
interest in the transaction, however, will not be deemed “material” within the meaning of
paragraph (b)(8) of this Item where the interest of the director, nominee, or Immediate Family
Member arises solely from the holding of an equity interest (including a limited partnership
interest, but excluding a general partnership interest) or a creditor interest in a company that
is a party to the transaction with one of the persons specified in paragraphs (b)(8)(i) through
(b)(8)(viii) of this Item, and the transaction is not material to the company.
8. The materiality of any interest is to be determined on the basis of the significance of the
information to investors in light of all the circumstances of the particular case. The
importance of the interest to the person having the interest, the relationship of the parties to
the transaction with each other, and the amount involved in the transaction are among the
factors to be considered in determining the significance of the information to investors.
9. No information need be given as to any transaction where the interest of the director,
nominee, or Immediate Family Member arises solely from the ownership of securities of a
person specified in paragraphs (b)(8)(i) through (b)(8)(viii) of this Item and the director,
nominee, or Immediate Family Member receives no extra or special benefit not shared on a
pro rata basis by all holders of the class of securities.
10. Transactions include loans, lines of credit, and other indebtedness. For indebtedness,
indicate the largest aggregate amount of indebtedness outstanding at any time during the
period, the nature of the indebtedness and the transaction in which it was incurred, the
amount outstanding as of the latest practicable date, and the rate of interest paid or
charged.
11. No information need be given as to any routine, retail transaction. For example, the Fund
need not disclose that a director has a credit card, bank or brokerage account, residential
mortgage, or insurance policy with a person specified in paragraphs (b)(8)(i) through (b)(8)
(viii) of this Item unless the director is accorded special treatment.

(9) Describe briefly any direct or indirect relationship, in which the amount involved exceeds $120,000, of any
director or nominee for election as director who is not or would not be an “interested person” of the Fund
within the meaning of section 2(a)(19) of the Investment Company Act of 1940 (15 U.S.C. 80a-2(a)(19)), or
Immediate Family Member of the director or nominee, that exists, or has existed at any time since the
beginning of the last two completed fiscal years of the Fund, or is currently proposed, with any of the persons
specified in paragraphs (b)(8)(i) through (b)(8)(viii) of this Item. Relationships include:

(i) Payments for property or services to or from any person specified in paragraphs (b)(8)(i) through (b)(8)(viii)
of this Item;
(ii) Provision of legal services to any person specified in paragraphs (b)(8)(i) through (b)(8)(viii) of this Item;
(iii) Provision of investment banking services to any person specified in paragraphs (b)(8)(i) through (b)(8)
(viii) of this Item, other than as a participating underwriter in a syndicate; and
(iv) Any consulting or other relationship that is substantially similar in nature and scope to the relationships
listed in paragraphs (b)(9)(i) through (b)(9)(iii) of this Item.

Instructions to paragraph (b)(9). 1. Include the name of each director, nominee, or Immediate
Family Member whose relationship is described and the nature of the circumstances by
reason of which the relationship is required to be described.
2. State the nature of the relationship and the amount of business conducted between the
director, nominee, or Immediate Family Member and the person specified in paragraphs (b)
(8)(i) through (b)(8)(viii) of this Item as a result of the relationship since the beginning of the
last two completed fiscal years of the Fund or proposed to be done during the Fund's current
fiscal year.
3. In computing the amount involved in a relationship, include all periodic payments in the
case of any agreement providing for periodic payments.
4. If the proxy statement relates to multiple portfolios of a series Fund with different fiscal
years, then, in determining the date that is the beginning of the last two completed fiscal
years of the Fund, use the earliest date of any series covered by the proxy statement.
5. Disclose indirect, as well as direct, relationships. A person who has a position or
relationship with, or interest in, a company that has a relationship with one of the persons
listed in paragraphs (b)(8)(i) through (b)(8)(viii) of this Item may have an indirect relationship
by reason of the position, relationship, or interest.
6. In determining whether the amount involved in a relationship exceeds $120,000, amounts
involved in a relationship of the director (or nominee) should be aggregated with those of his
Immediate Family Members.
7. In the case of an indirect interest, identify the company with which a person specified in
paragraphs (b)(8)(i) through (b)(8)(viii) of this Item has a relationship; the name of the
director, nominee, or Immediate Family Member affiliated with the company and the nature
of the affiliation; and the amount of business conducted between the company and the
person specified in paragraphs (b)(8)(i) through (b)(8)(viii) of this Item since the beginning of
the last two completed fiscal years of the Fund or proposed to be done during the Fund's
current fiscal year.
8. In calculating payments for property and services for purposes of paragraph (b)(9)(i) of
this Item, the following may be excluded:
A. Payments where the transaction involves the rendering of services as a common contract
carrier, or public utility, at rates or charges fixed in conformity with law or governmental
authority; or
B. Payments that arise solely from the ownership of securities of a person specified in
paragraphs (b)(8)(i) through (b)(8)(viii) of this Item and no extra or special benefit not shared
on a pro rata basis by all holders of the class of securities is received.

9. No information need be given as to any routine, retail relationship. For example, the Fund
need not disclose that a director has a credit card, bank or brokerage account, residential
mortgage, or insurance policy with a person specified in paragraphs (b)(8)(i) through (b)(8)
(viii) of this Item unless the director is accorded special treatment.

(10) If an Officer of an investment adviser, principal underwriter, or Sponsoring Insurance Company of the
Fund, or an Officer of a person directly or indirectly controlling, controlled by, or under common control with an
investment adviser, principal underwriter, or Sponsoring Insurance Company of the Fund, serves, or has
served since the beginning of the last two completed fiscal years of the Fund, on the board of directors of a
company where a director of the Fund or nominee for election as director who is not or would not be an
“interested person” of the Fund within the meaning of section 2(a)(19) of the Investment Company Act of
1940 (15 U.S.C. 80a-2(a)(19)), or Immediate Family Member of the director or nominee, is, or was since the
beginning of the last two completed fiscal years of the Fund, an Officer, identify:
(i) The company;
(ii) The individual who serves or has served as a director of the company and the period of service as director;
(iii) The investment adviser, principal underwriter, or Sponsoring Insurance Company or person controlling,
controlled by, or under common control with the investment adviser, principal underwriter, or Sponsoring
Insurance Company where the individual named in paragraph (b)(10)(ii) of this Item holds or held office and
the office held; and
(iv) The director of the Fund, nominee for election as director, or Immediate Family Member who is or was an
Officer of the company; the office held; and the period of holding the office.

Instruction to paragraph (b)(10). If the proxy statement relates to multiple portfolios of a
series Fund with different fiscal years, then, in determining the date that is the beginning of the
last two completed fiscal years of the Fund, use the earliest date of any series covered by the
proxy statement.
(11) Provide in tabular form, to the extent practicable, the information required by Items 401(f) and (g), 404(a),
405, and 407(h) of Regulation S-K (§§ 229.401(f) and (g), 229.404(a), 229.405, and 229.407(h) of this
chapter).

Instruction to paragraph (b)(11). Information provided under paragraph (b)(8) of this Item 22
is deemed to satisfy the requirements of Item 404(a) of Regulation S-K for information about
directors, nominees for election as directors, and Immediate Family Members of directors and
nominees, and need not be provided under this paragraph (b)(11).
(12) Describe briefly any material pending legal proceedings, other than ordinary routine litigation incidental to
the Fund's business, to which any director or nominee for director or affiliated person of such director or
nominee is a party adverse to the Fund or any of its affiliated persons or has a material interest adverse to the
Fund or any of its affiliated persons. Include the name of the court where the case is pending, the date
instituted, the principal parties, a description of the factual basis alleged to underlie the proceeding, and the
relief sought.

(13) In the case of a Fund that is an investment company registered under the Investment Company Act of
1940 (15 U.S.C. 80a), for all directors, and for each of the three highest-paid Officers that have aggregate
compensation from the Fund for the most recently completed fiscal year in excess of $60,000 (“Compensated
Persons”):
(i) Furnish the information required by the following table for the last fiscal year:

Compensation Table
(1)

(2)

(3)

(4)

(5)

Name of

Aggregate

Pension or

Estimated

Total

Person,

Compensation

Retirement

Annual

Compensation

Position

From Fund

Benefits

Benefits

From Fund and

Accrued as

Upon

Complex Paid to

Part of Fund

Retirement

Directors

Expenses

Instructions to paragraph (b)(13)(i). 1. For column (1), indicate, if necessary, the capacity in
which the remuneration is received. For Compensated Persons that are directors of the Fund,
compensation is amounts received for service as a director.
2. If the Fund has not completed its first full year since its organization, furnish the
information for the current fiscal year, estimating future payments that would be made
pursuant to an existing agreement or understanding. Disclose in a footnote to the
Compensation Table the period for which the information is furnished.
3. Include in column (2) amounts deferred at the election of the Compensated Person,
whether pursuant to a plan established under Section 401(k) of the Internal Revenue Code
(26 U.S.C. 401(k)) or otherwise, for the fiscal year in which earned. Disclose in a footnote to
the Compensation Table the total amount of deferred compensation (including interest)
payable to or accrued for any Compensated Person.
4. Include in columns (3) and (4) all pension or retirement benefits proposed to be paid under
any existing plan in the event of retirement at normal retirement date, directly or indirectly, by
the Fund or any of its Subsidiaries, or by other companies in the Fund Complex. Omit column
(4) where retirement benefits are not determinable.
5. For any defined benefit or actuarial plan under which benefits are determined primarily by
final compensation (or average final compensation) and years of service, provide the
information required in column (4) in a separate table showing estimated annual benefits
payable upon retirement (including amounts attributable to any defined benefit
supplementary or excess pension award plans) in specified compensation and years of
service classifications. Also provide the estimated credited years of service for each
Compensated Person.

6. Include in column (5) only aggregate compensation paid to a director for service on the
board and other boards of investment companies in a Fund Complex specifying the number
of such other investment companies.

(ii) Describe briefly the material provisions of any pension, retirement, or other plan or any arrangement other
than fee arrangements disclosed in paragraph (b)(13)(i) of this Item pursuant to which Compensated Persons
are or may be compensated for any services provided, including amounts paid, if any, to the Compensated
Person under any such arrangements during the most recently completed fiscal year. Specifically include the
criteria used to determine amounts payable under any plan, the length of service or vesting period required by
the plan, the retirement age or other event that gives rise to payments under the plan, and whether the
payment of benefits is secured or funded by the Fund.
(14) State whether or not the Fund has a separately designated audit committee established in accordance
with section 3(a)(58)(A) of the Act (15 U.S.C. 78c(a)(58)(A)). If the entire board of directors is acting as the
Fund's audit committee as specified in section 3(a)(58)(B) of the Act (15 U.S.C. 78c(a)(58)(B)), so state. If
applicable, provide the disclosure required by § 240.10A-3(d) regarding an exemption from the listing
standards for audit committees. Identify the other standing committees of the Fund's board of directors, and
provide the following information about each committee, including any separately designated audit
committee and any nominating committee:
(i) A concise statement of the functions of the committee;
(ii) The members of the committee and, in the case of a nominating committee, whether or not the members
of the committee are “interested persons” of the Fund as defined in section 2(a)(19) of the Investment
Company Act of 1940 (15 U.S.C. 80a-2(a)(19)); and
(iii) The number of committee meetings held during the last fiscal year.

Instruction to paragraph (b)(14): For purposes of Item 22(b)(14), the term “nominating
committee” refers not only to nominating committees and committees performing similar
functions, but also to groups of directors fulfilling the role of a nominating committee,
including the entire board of directors.
(15)(i) Provide the information (and in the format) required by Items 407(b)(1), (b)(2) and (f) of Regulation S-K
(§ 229.407(b)(1), (b)(2) and (f) of this chapter); and
(ii) Provide the following regarding the requirements for the director nomination process:
(A) The information (and in the format) required by Items 407(c)(1) and (c)(2) of Regulation S-K (§ 229.407(c)
(1) and (c)(2) of this chapter); and
(B) If the Fund is a listed issuer (as defined in § 240.10A-3 of this chapter) whose securities are listed on a
national securities exchange registered pursuant to section 6(a) of the Act (15 U.S.C. 78f(a)) or in an
automated inter-dealer quotation system of a national securities association registered pursuant to section
15A of the Act (15 U.S.C. 78o-3(a)) that has independence requirements for nominating committee members,
identify each director that is a member of the nominating committee that is not independent under the
independence standards described in this paragraph. In determining whether the nominating committee
members are independent, use the Fund's definition of independence that it uses for determining if the

members of the nominating committee are independent in compliance with the independence standards
applicable for the members of the nominating committee in the listing standards applicable to the Fund. If the
Fund does not have independence standards for the nominating committee, use the independence standards
for the nominating committee in the listing standards applicable to the Fund.

Instruction to paragraph (b)(15)(ii)(B). If the national securities exchange or inter-dealer
quotation system on which the Fund's securities are listed has exemptions to the
independence requirements for nominating committee members upon which the Fund relied,
disclose the exemption relied upon and explain the basis for the Fund's conclusion that such
exemption is applicable.
(16) In the case of a Fund that is a closed-end investment company:
(i) Provide the information (and in the format) required by Item 407(d)(1), (d)(2) and (d)(3) of Regulation S-K
(§ 229.407(d)(1), (d)(2) and (d)(3) of this chapter); and
(ii) Identify each director that is a member of the Fund's audit committee that is not independent under the
independence standards described in this paragraph. If the Fund does not have a separately designated audit
committee, or committee performing similar functions, the Fund must provide the disclosure with respect to
all members of its board of directors.
(A) If the Fund is a listed issuer (as defined in § 240.10A-3 of this chapter) whose securities are listed on a
national securities exchange registered pursuant to section 6(a) of the Act (15 U.S.C. 78f(a)) or in an
automated inter-dealer quotation system of a national securities association registered pursuant to section
15A of the Act (15 U.S.C. 78o-3(a)) that has independence requirements for audit committee members, in
determining whether the audit committee members are independent, use the Fund's definition of
independence that it uses for determining if the members of the audit committee are independent in
compliance with the independence standards applicable for the members of the audit committee in the listing
standards applicable to the Fund. If the Fund does not have independence standards for the audit committee,
use the independence standards for the audit committee in the listing standards applicable to the Fund.
(B) If the Fund is not a listed issuer whose securities are listed on a national securities exchange registered
pursuant to section 6(a) of the Act (15 U.S.C. 78f(a)) or in an automated inter-dealer quotation system of a
national securities association registered pursuant to section 15A of the Act (15 U.S.C. 78o-3(a)), in
determining whether the audit committee members are independent, use a definition of independence of a
national securities exchange registered pursuant to section 6(a) of the Act (15 U.S.C. 78f(a)) or an automated
inter-dealer quotation system of a national securities association registered pursuant to section 15A of the
Act (15 U.S.C. 780-3(a)) which has requirements that a majority of the board of directors be independent and
that has been approved by the Commission, and state which definition is used. Whatever such definition the
Fund chooses, it must use the same definition with respect to all directors and nominees for director. If the
national securities exchange or national securities association whose standards are used has independence
standards for the members of the audit committee, use those specific standards.

Instruction to paragraph (b)(16)(ii). If the national securities exchange or inter-dealer
quotation system on which the Fund's securities are listed has exemptions to the
independence requirements for nominating committee members upon which the Fund relied,
disclose the exemption relied upon and explain the basis for the Fund's conclusion that such
exemption is applicable. The same disclosure should be provided if the Fund is not a listed

issuer and the national securities exchange or inter-dealer quotation system selected by the
Fund has exemptions that are applicable to the Fund.
(17) In the case of a Fund that is an investment company registered under the Investment Company Act of
1940 (15 U.S.C. 80a), if a director has resigned or declined to stand for re-election to the board of directors
since the date of the last annual meeting of security holders because of a disagreement with the registrant on
any matter relating to the registrant's operations, policies or practices, and if the director has furnished the
registrant with a letter describing such disagreement and requesting that the matter be disclosed, the
registrant shall state the date of resignation or declination to stand for re-election and summarize the
director's description of the disagreement. If the registrant believes that the description provided by the
director is incorrect or incomplete, it may include a brief statement presenting its view of the disagreement.
(18) [Reserved]
(19) If a Fund is required to include a shareholder nominee or nominees submitted to the Fund for inclusion in
the Fund's proxy materials pursuant to a procedure set forth under applicable state or foreign law or the
Fund's governing documents providing for the inclusion of shareholder director nominees in the Fund's proxy
materials, the Fund must include in its proxy statement the disclosure required from the nominating
shareholder or nominating shareholder group under Item 6 of § 240.14n-101 with regard to the nominee or
nominees and the nominating shareholder or nominating shareholder group.

Instruction to paragraph (b)(19). The information disclosed pursuant to paragraph (b)(19) of
this Item will not be deemed incorporated by reference into any filing under the Securities Act
of 1933 (15 U.S.C. 77a et seq.), the Securities Exchange Act of 1934 (15 U.S.C. 78a et seq.), or
the Investment Company Act of 1940 (15 U.S.C. 80a-1 et seq.), except to the extent that the
Fund specifically incorporates that information by reference.
(20) In the case of a Fund that is an investment company registered under the Investment Company Act of
1940 (15 U.S.C. 80a) that is required to develop and implement a policy regarding the recovery of erroneously
awarded compensation pursuant to § 240.10D-1(b)(1), if at any time during the last completed fiscal year the
Fund was required to prepare an accounting restatement that required recovery of erroneously awarded
compensation pursuant to the Fund's compensation recovery policy required by the listing standards adopted
pursuant to 240.10D-1, or there was an outstanding balance as of the end of the last completed fiscal year of
erroneously awarded compensation to be recovered from the application of the policy to a prior restatement,
the Fund must provide the information required by Item 18 of Form N-CSR, as applicable.
(c) Approval of investment advisory contract. If action is to be taken with respect to an investment advisory
contract, include the following information in the proxy statement.

Instruction. Furnish information with respect to a prospective investment adviser to the extent applicable
(including the name and address of the prospective investment adviser).
(1) With respect to the existing investment advisory contract:
(i)

State the date of the contract and the date on which it was last submitted to a vote of security
holders of the Fund, including the purpose of such submission;

(ii)

Briefly describe the terms of the contract, including the rate of compensation of the investment
adviser;

(iii) State the aggregate amount of the investment adviser's fee and the amount and purpose of
any other material payments by the Fund to the investment adviser, or any affiliated person of
the investment adviser, during the last fiscal year of the Fund;
(iv) If any person is acting as an investment adviser of the Fund other than pursuant to a written
contract that has been approved by the security holders of the company, identify the person
and describe the nature of the services and arrangements;
(v)

Describe any action taken with respect to the investment advisory contract since the beginning
of the Fund's last fiscal year by the board of directors of the Fund (unless described in
response to paragraph (c)(1)(vi)) of this Item 22); and

(vi) If an investment advisory contract was terminated or not renewed for any reason, state the
date of such termination or non-renewal, identify the parties involved, and describe the
circumstances of such termination or non-renewal.
(2) State the name, address and principal occupation of the principal executive officer and
each director or general partner of the investment adviser.

Instruction. If the investment adviser is a partnership with more than ten general partners, name:
(i)

The general partners with the five largest economic interests in the partnership, and, if
different, those general partners comprising the management or executive committee of the
partnership or exercising similar authority;

(ii)

The general partners with significant management responsibilities relating to the fund.
(3) State the names and addresses of all Parents of the investment adviser and show the basis
of control of the investment adviser and each Parent by its immediate Parent.

Instructions. 1. If any person named is a corporation, include the percentage of its voting securities
owned by its immediate Parent.
2. If any person named is a partnership, name the general partners having the three largest
partnership interests (computed by whatever method is appropriate in the particular case).
(4) If the investment adviser is a corporation and if, to the knowledge of the persons making the
solicitation or the persons on whose behalf the solicitation is made, any person not named in
answer to paragraph (c)(3) of this Item 22 owns, of record or beneficially, ten percent or more of the
outstanding voting securities of the investment adviser, indicate that fact and state the name and
address of each such person.
(5) Name each officer or director of the Fund who is an officer, employee, director, general partner or
shareholder of the investment adviser. As to any officer or director who is not a director or general
partner of the investment adviser and who owns securities or has any other material direct or
indirect interest in the investment adviser or any other person controlling, controlled by or under
common control with the investment adviser, describe the nature of such interest.
(6) Describe briefly and state the approximate amount of, where practicable, any material interest,
direct or indirect, of any director of the Fund in any material transactions since the beginning of the
most recently completed fiscal year, or in any material proposed transactions, to which the
investment adviser of the Fund, any Parent or Subsidiary of the investment adviser (other than
another Fund), or any Subsidiary of the Parent of such entities was or is to be a party.

Instructions. 1. Include the name of each person whose interest in any transaction is described and the
nature of the relationship by reason of which such interest is required to be described. Where it is
not practicable to state the approximate amount of the interest, indicate the approximate amount
involved in the transaction.
2. As to any transaction involving the purchase or sale of assets by or to the investment adviser,
state the cost of the assets to the purchaser and the cost thereof to the seller if acquired by the
seller within two years prior to the transaction.
3. If the interest of any person arises from the position of the person as a partner in a partnership,
the proportionate interest of such person in transactions to which the partnership is a party need
not be set forth, but state the amount involved in the transaction with the partnership.
4. No information need be given in response to this paragraph (c)(6) of Item 22 with respect to any
transaction that is not related to the business or operations of the Fund and to which neither the
Fund nor any of its Parents or Subsidiaries is a party.
(7) Disclose any financial condition of the investment adviser that is reasonably likely to impair the
financial ability of the adviser to fulfill its commitment to the fund under the proposed investment
advisory contract.
(8) Describe the nature of the action to be taken on the investment advisory contract and the
reasons therefor, the terms of the contract to be acted upon, and, if the action is an amendment to,
or a replacement of, an investment advisory contract, the material differences between the current
and proposed contract.
(9) If a change in the investment advisory fee is sought, state:
(i)

The aggregate amount of the investment adviser's fee during the last year;

(ii)

The amount that the adviser would have received had the proposed fee been in effect; and

(iii) The difference between the aggregate amounts stated in response to paragraphs (i) and (ii) of
this item (c)(9) as a percentage of the amount stated in response to paragraph (i) of this item
(c)(9).
(10) If the investment adviser acts as such with respect to any other Fund having a similar
investment objective, identify and state the size of such other Fund and the rate of the
investment adviser's compensation. Also indicate for any Fund identified whether the
investment adviser has waived, reduced, or otherwise agreed to reduce its compensation
under any applicable contract.

Instruction. Furnish the information in response to this paragraph (c)(10) of Item 22 in tabular form.
(11) Discuss in reasonable detail the material factors and the conclusions with respect thereto that
form the basis for the recommendation of the board of directors that the shareholders approve an
investment advisory contract. Include the following in the discussion:
(i)

Factors relating to both the board's selection of the investment adviser and approval of the
advisory fee and any other amounts to be paid by the Fund under the contract. This would
include, but not be limited to, a discussion of the nature, extent, and quality of the services to
be provided by the investment adviser; the investment performance of the Fund and the
investment adviser; the costs of the services to be provided and profits to be realized by the
investment adviser and its affiliates from the relationship with the Fund; the extent to which
economies of scale would be realized as the Fund grows; and whether fee levels reflect these
economies of scale for the benefit of Fund investors. Also indicate in the discussion whether

the board relied upon comparisons of the services to be rendered and the amounts to be paid
under the contract with those under other investment advisory contracts, such as contracts of
the same and other investment advisers with other registered investment companies or other
types of clients (e.g., pension funds and other institutional investors). If the board relied upon
such comparisons, describe the comparisons that were relied on and how they assisted the
board in determining to recommend that the shareholders approve the advisory contract; and
(ii)

If applicable, any benefits derived or to be derived by the investment adviser from the
relationship with the Fund such as soft dollar arrangements by which brokers provide research
to the Fund or its investment adviser in return for allocating Fund brokerage.

Instructions. 1. Conclusory statements or a list of factors will not be considered sufficient disclosure.
Relate the factors to the specific circumstances of the Fund and the investment advisory contract
for which approval is sought and state how the board evaluated each factor. For example, it is not
sufficient to state that the board considered the amount of the investment advisory fee without
stating what the board concluded about the amount of the fee and how that affected its
determination to recommend approval of the contract.
2. If any factor enumerated in paragraph (c)(11)(i) of this Item 22 is not relevant to the board's
evaluation of the investment advisory contract for which approval is sought, note this and explain
the reasons why that factor is not relevant.
(12) Describe any arrangement or understanding made in connection with the proposed investment
advisory contract with respect to the composition of the board of directors of the Fund or the
investment adviser or with respect to the selection or appointment of any person to any office with
either such company.
(13) For the most recently completed fiscal year, state:
(i)

The aggregate amount of commissions paid to any Affiliated Broker; and

(ii)

The percentage of the Fund's aggregate brokerage commissions paid to any such Affiliated
Broker.

Instruction. Identify each Affiliated Broker and the relationships that cause the broker to be an Affiliated
Broker.
(14) Disclose the amount of any fees paid by the Fund to the investment adviser, its affiliated
persons or any affiliated person of such person during the most recent fiscal year for services
provided to the Fund (other than under the investment advisory contract or for brokerage
commissions). State whether these services will continue to be provided after the investment
advisory contract is approved.
(d) Approval of distribution plan. If action is to be taken with respect to a Distribution Plan, include
the following information in the proxy statement.

Instruction. Furnish information on a prospective basis to the extent applicable.
(1) Describe the nature of the action to be taken on the Distribution Plan and the reason therefor, the
terms of the Distribution Plan to be acted upon, and, if the action is an amendment to, or a
replacement of, a Distribution Plan, the material differences between the current and proposed
Distribution Plan.
(2) If the Fund has a Distribution Plan in effect:
(i)

Provide the date that the Distribution Plan was adopted and the date of the last amendment, if
any;

(ii)

Disclose the persons to whom payments may be made under the Distribution Plan, the rate of
the distribution fee and the purposes for which such fee may be used;

(iii) Disclose the amount of distribution fees paid by the Fund pursuant to the plan during its most
recent fiscal year, both in the aggregate and as a percentage of the Fund's average net assets
during the period;
(iv) Disclose the name of, and the amount of any payments made under the Distribution Plan by
the Fund during its most recent fiscal year to, any person who is an affiliated person of the
Fund, its investment adviser, principal underwriter, or Administrator, an affiliated person of
such person, or a person that during the most recent fiscal year received 10% or more of the
aggregate amount paid under the Distribution Plan by the Fund;
(v)

Describe any action taken with respect to the Distribution Plan since the beginning of the
Fund's most recent fiscal year by the board of directors of the Fund; and

(vi) If a Distribution Plan was or is to be terminated or not renewed for any reason, state the date or
prospective date of such termination or non-renewal, identify the parties involved, and describe
the circumstances of such termination or non-renewal.

(3) Describe briefly and state the approximate amount of, where practicable, any material interest, direct or
indirect, of any director or nominee for election as a director of the Fund in any material transactions since the
beginning of the most recently completed fiscal year, or in any material proposed transactions, to which any
person identified in response to Item 22(d)(2)(iv) was or is to be a party.

Instructions. 1. Include the name of each person whose interest in any transaction is described and
the nature of the relationship by reason of which such interest is required to be described. Where it
is not practicable to state the approximate amount of the interest, indicate the approximate amount
involved in the transaction.

2. As to any transaction involving the purchase or sale of assets, state the cost of the assets to the purchaser
and the cost thereof to the seller if acquired by the seller within two years prior to the transaction.
3. If the interest of any person arises from the position of the person as a partner in a partnership, the
proportionate interest of such person in transactions to which the partnership is a party need not be set forth
but state the amount involved in the transaction with the partnership.
4. No information need be given in response to this paragraph (d)(3) of Item 22 with respect to any
transaction that is not related to the business or operations of the Fund and to which neither the Fund nor any
of its Parents or Subsidiaries is a party.
(4) Discuss in reasonable detail the material factors and the conclusions with respect thereto which form the
basis for the conclusion of the board of directors that there is a reasonable likelihood that the proposed
Distribution Plan (or amendment thereto) will benefit the Fund and its shareholders.

Instruction. Conclusory statements or a list of factors will not be considered sufficient disclosure.
Item 23. Delivery of documents to security holders sharing an address. If one annual report to
security holders, proxy statement, or Notice of Internet Availability of Proxy Materials is being
delivered to two or more security holders who share an address in accordance with § 240.14a-3(e)
(1), furnish the following information:

(a) State that only one annual report to security holders, proxy statement, or Notice of Internet
Availability of Proxy Materials, as applicable, is being delivered to multiple security holders
sharing an address unless the registrant has received contrary instructions from one or more
of the security holders;
(b) Undertake to deliver promptly upon written or oral request a separate copy of the annual report
to security holders, proxy statement, or Notice of Internet Availability of Proxy Materials, as
applicable, to a security holder at a shared address to which a single copy of the documents
was delivered and provide instructions as to how a security holder can notify the registrant
that the security holder wishes to receive a separate copy of an annual report to security
holders, proxy statement, or Notice of Internet Availability of Proxy Materials, as applicable;
(c)

Provide the phone number and mailing address to which a security holder can direct a
notification to the registrant that the security holder wishes to receive a separate annual report
to security holders, proxy statement, or Notice of Internet Availability of Proxy Materials, as
applicable, in the future; and

(d) Provide instructions how security holders sharing an address can request delivery of a single
copy of annual reports to security holders, proxy statements, or Notices of Internet Availability
of Proxy Materials if they are receiving multiple copies of annual reports to security holders,
proxy statements, or Notices of Internet Availability of Proxy Materials.

Item 24. Shareholder Approval of Executive Compensation. Registrants required to provide any of the
separate shareholder votes pursuant to § 240.14a-21 of this chapter shall disclose that they are
providing each such vote as required pursuant to section 14A of the Securities Exchange Act (15
U.S.C. 78n-1), briefly explain the general effect of each vote, such as whether each such vote is nonbinding, and, when applicable, disclose the current frequency of shareholder advisory votes on
executive compensation required by Rule 14a-21(a) and when the next such shareholder advisory
vote will occur.
Item 25. Exhibits. Provide each of the following in an exhibit to this Schedule 14A:
(a) The legal opinion required to be filed by Item 402(u)(4)(i) of Regulation S-K (17 CFR
229.402(u));
(b) If the transaction is a de-SPAC transaction, as defined in § 229.1601(a) (Item 1601(a) of
Regulation S-K), all reports, opinions, or appraisals required to be filed or included by §
229.1607(c) (Item 1607(c) of Regulation S-K); and
(c)

If a fee is required, the title of each class of securities to which the transaction applies,
aggregate number of securities to which the transaction applies, per unit price or other
underlying value of the transaction computed pursuant to § 240.0-11, proposed maximum
aggregate value of the transaction, fee rate, amount of filing fee and, as applicable, information
relating to reliance on § 240.0-11(a)(2) in the tabular form indicated.

Registered funds that must pay registration fees using Form 24F-2 (§ 274.24) are not required to respond to
this Item.

Calculation of Filing Fee Tables

Table 1—Transaction Valuation
Proposed
maximum
aggregate

Fee rate

Amount of

value of

filing fee

transaction
Fees to Be Paid

X

Fees Previously Paid

X

Total Transaction Valuation

X

X
X

X

Total Fees Due for Filing

X

Total Fees Previously Paid

X

Total Fee Offsets

X

Net Fee Due

X

Table 2—Fee Offset Claims and Sources

Registrant
or filer
name

Fee

Fee

Form
or

File

filing

number

type

Initial
filing
date

Filing
date

Fee

paid

offset

with fee

claimed

offset
source

X

X

X

X

X

X

Offset
Claims
Fee

X

X

Offset
Sources

Instructions to the Calculation of Filing Fee Tables and Related Disclosure (“Instructions”):

1. General Requirements.

X

A. Applicable Table Requirements.
The “X” designation indicates the information required to be disclosed, as applicable, in tabular format. Add
as many rows of each table as necessary.
B. Fee Rate.
For the current fee rate, see https://www.sec.gov/ofm/Article/feeamt.html.
C. Explanations.
Disclose the (i) title of each class of securities to which the transaction applies; (ii) aggregate number of
securities to which the transaction apples; and (iii) per unit price or other underlying value of the transaction
computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and
state how it was determined). If not otherwise explained in response to these instructions, disclose specific
details relating to the fee calculation as necessary to clarify the information presented in each table, including
references to the applicable provisions of Rule 0-11 (§ 240.0-11 of this chapter). All disclosure these
Instructions require that is not specifically required to be presented in tabular format must appear in narrative
format immediately after the table(s) to which it corresponds.
D. Submission Method.
If a filing fee exhibit is required to be provided pursuant to this Item 25(b), it must be submitted as required by
Rule 408 of Regulation S-T (§ 232.408 of this chapter).
2. Table 1: Transaction Valuation Table and Related Disclosure.
A. Fees to Be Paid and Fees Previously Paid.
i. Fees to Be Paid.
Provide the information Table 1 requires for the line item “Fees to Be Paid” as follows:
b. Initial Filings.
For an initial filing on this schedule, provide the required information for the total transaction valuation.
c. Amendments with Then-Current Total Transaction Valuation Higher than Highest Total Transaction
Valuation Previously Reported.
For amendments to this schedule that reflect a then-current total transaction valuation higher than the highest
total transaction valuation previously reported, provide the required information for the incremental increase.
ii. Fees Previously Paid.
Provide the information Table 1 requires for the line item “Fees Previously Paid” for the prior initial filing or
amendment to this schedule that reflected a then-current total transaction valuation that was the highest total
transaction valuation previously reported.
B. Other Tabular Information.

Provide the following information in the table for the line items “Fees to be Paid” and “Fees Previously Paid”,
as applicable:
i. The proposed maximum aggregate value of the transaction computed pursuant to Exchange Act Rule 0-11;
ii. The fee rate; and
iii. The filing fee due without regard to any previous payments or offsets.
C. Totals.
i. Total Transaction Valuation.
Provide the sum of the proposed maximum aggregate values for the line items “Fees to Be Paid” and “Fees
Previously Paid”.
ii. Total Fees Due for Filing.
Provide the sum of the fees due without regard to any previous payments or offsets for the line items “Fees to
be Paid” and “Fees Previously Paid.”
iii. Total Fees Previously Paid.
Provide the aggregate of filing fees previously paid with this filing.
iv. Total Fee Offsets.
Provide the aggregate of the fee offsets that are claimed in Table 2 pursuant to Instruction 3.
v. Net Fee Due.
Provide the difference between (a) the total fees due for this schedule from the Total Fees Due for Filing row;
and (b) the sum of (i) the aggregate of filing fees previously paid from the Total Fees Previously Paid row; and
(ii) the aggregate fee offsets claimed from the Total Fee Offsets row.
D. Narrative Disclosure.
Explain how the transaction valuation was determined.
3. Table 2: Fee Offset Claims and Sources.
A. Terminology.
For purposes of this Instruction 3 and Table 2, the term “submission” means any (i) initial filing of, or
amendment (pre-effective or post-effective), to a fee-bearing document; or (ii) fee-bearing form of prospectus
filed under Rule 424 under the Securities Act (§ 230.424 of this chapter), in all cases that was accompanied
by a contemporaneous fee payment. For purposes of these instructions to Table 2, a contemporaneous fee
payment is the payment of a required fee that is satisfied through the actual transfer of funds, and does not
include any amount of a required fee satisfied through a claimed fee offset. Instruction 3.B.ii requires a filer

that claims a fee offset under Rule 0-11(a)(2) to identify previous submissions with contemporaneous fee
payments that are the original source to which the fee offsets claimed on this filing can be traced. See
Instruction 3.C for an example.
B. Rule 0-11(a)(2).
If relying on Rule 0-11(a)(2) to offset some or all of the filing fee due on this schedule by amounts paid in
connection with earlier filings (other than this Schedule 14A) relating to the same transaction, provide the
following information:
i. Fee Offset Claims.
For each earlier filed Securities Act registration statement or Exchange Act document relating to the same
transaction from which a fee offset is being claimed, provide the information that Table 2 requires for the line
item “Fee Offset Claims”. The “Fee Offset Claimed” column requires the dollar amount of the previously paid
filing fee to be offset against the currently due fee.
Note to Instruction 3.B.i.
If claiming an offset from a Securities Act registration statement, provide a detailed explanation of the basis
for the claimed offset.
ii. Fee Offset Sources.
With respect to amounts claimed as an offset under Rule 0-11(a)(2), identify those submissions with
contemporaneous fee payments that are the original source to which those amounts can be traced. For each
submission identified, provide the information that Table 2 requires for the line item “Fee Offset Sources”. The
“Fee Paid with Fee Offset Source” column requires the dollar amount of the contemporaneous fee payment
made with respect to each identified submission that is the source of the fee offset claimed pursuant to Rule
0-11(a)(2).
C. Fee Offset Source Submission Identification Example.
A filer:
• Initially files a registration statement on Form S-1 on 1/15/20X1 (assigned file number 333-123456) with a
fee payment of $10,000;
• Files pre-effective amendment number 1 to the Form S-1 (333-123456) on 2/15/20X1 with a fee payment of
$15,000 and the registration statement goes effective on 2/20/20X1;
• Initially files a registration statement on Form S-1 on 1/15/20X4 (assigned file number 333-123467) with a
fee payment of $25,000 and relies on Rule 457(p) to claim an offset of $10,000 related to the unsold
securities registered on the previously filed Form S-1 (333-123456) and apply it to the $35,000 filing fee due
and the registration statement goes effective on 2/15/20X4.
• Initially files a registration statement related to a tender offer on Form S-4 (assigned file number 333123478) on 1/15/20X7 with a fee payment of $15,000 and relies on Rule 457(p) to claim an offset of $30,000
related to the unsold securities registered on the most recently effective Form S-1 (333-123467) filed on
1/15/20X4 and apply it to the $45,000 filing fee due.

• Initially files a Schedule TO related to the same tender offer on 1/22/20X7 and relies on Rule 0-11(a)(2) to
claim an offset of $45,000 from the fee paid directly and by offset claimed on the Form S-4 (333-123478) filed
1/15/20X7 and apply it to the $45,000 filing fee due.
For the Schedule TO filed on 1/22/20X7, the filer can satisfy the submission identification requirement when it
claims the $45,000 fee offset from the Form S-4 (333-123478) filed on 1/15/20X7 by referencing any
combination of the Form S-4 (333-123478) filed on 1/15/20X7, the Form S-1 (333-123467) filed on
1/15/20X4, the pre-effective amendment to the Form S-1 (333-123456) filed on 2/15/20X1 or the initial filing
of the Form S-1 (333-123456) on 1/15/20X1 in relation to which contemporaneous fee payments were made
equal to $45,000. One example could be:
• The Form S-4 (333-123478) filed on 1/15/20X7 in relation to the payment of $15,000 made with that
submission;
• the Form S-1 (333-123467) filed on 1/15/20X4 in relation to the payment of $25,000 made with that
submission; and
• the pre-effective amendment to the Form S-1 (333-123456) filed on 2/15/20X1 in relation to the payment of
$5,000 out of the payment of $15,000 made with that submission (it would not matter if the filer cited to this
pre-effective amendment and/or the initial submission of this Form S-1 (333-123456) on 1/15/20X1 as long
as singly or together they were cited as relating to a total of $5,000 in this example).
In this example, the filer could not satisfy the submission identification requirement solely by citing to the
Form S-4 (333-123478) filed on 1/15/20X7 because even though the offset claimed and available from that
filing was $45,000, the contemporaneous fee payment made with that filing ($15,000) was less than the offset
being claimed. As a result, the filer must also identify a prior submission or submissions with an aggregate of
contemporaneous fee payment(s) of $30,000 as the original source(s) to which the rest of the claimed offset
can be traced.

[51 FR 42063, Nov. 20, 1986; 51 FR 45576, Dec. 19, 1986]
EDITORIAL NOTE

Editorial Note: For Federal Register citations affecting § 240.14a-101, see the List of CFR Sections
Affected, which appears in the Finding Aids section of the printed volume and at www.govinfo.gov.